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Chromatin functions as a physical barrier regulating access to DNA, however pioneer factors are
able to engage partial recognition motifs present within nucleosomal DNA to initiate access to specific
DNA sequences. During spermatogenesis, genomic locations that become recombination hotspots are
generally in regions of closed chromatin, or heterochromatin, before meiosis. However, in leptotene and
zygotene stages of meiosis, PRDM9 marks nucleosomes at recombination hotspots with H3K4me3 and
H3K36me3 and recruits other factors that deposit additional histone marks. Here I focus on the
technological approaches by which we discovered that hotspots also transition from closed to open
chromatin, dependent on the chromatin remodeler HELLS. HELLS and PRDM9 form a pioneer complex
that targets hotspot sequences and provides access for the DNA double-strand break (DSB) machinery.
Failure to reorganize chromatin at hotspots into an open conformation leads to DSBs at other open
regions, such as promotors, causing a breakdown in recombination and cell death.
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CHAPTER 1
STATEMENT OF PURPOSE
1.1. Description of thesis goal
The purpose of this document is to describe the process of discovery that took place over three years
and culminated in a paper co-authored by myself and other lab members, HELLS and PRDM9 form a
pioneer complex to open chromatin at meiotic recombination hot spots, Genes Dev, 2020. Though I will
cover the results of our experiments and our findings, the more structured and polished scientific
significance of our work is in the published paper. My thesis will focus on the technologies that I used
and follow the chronological course of my work, illustrating the successes and enigmas we encountered
that inspired our work, and how we built on these to elucidate the novel role for Hells in meiosis and
fertility. In this thesis, I will use first person singular to refer to work that I conducted, and first person
plural to refer to work done in collaboration with other lab members, particularly my advisor, Dr. Baker.
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CHAPTER 2
INTRODUCTION
2.1. Chromatin is remodeled to permit homologous recombination
Homologous recombination is a defining event in meiosis when programmed double-stranded DNA
breaks (DSBs) initiate a homology search resulting in homologous chromosome pairing and the
resolution of the DSBs through exchange of genetic material. These programmed DSBs occur at
hotspots, which are specialized sites that can be recognized by PRDM9 (Paigen and Petkov, 2010;
Baudat et al., 2013). PRDM9 is a meiotic protein that is expressed in leptotene to zygotene stage of
prophase I. The PRDM9 protein has several conserved domains; including a PR/SET domain for
methylation of histones (Hohenauer and Moore, 2012, Mzoughi et al., 2016), KRAB-related (Krüppelassociated box) and an SSXRD (SSX repression domain) domain for protein interactions (Imai et al., 2017,
Parvanov et al., 2017), and a DNA-binding domain composed of a tandem array of C2H2 zinc fingers
(Hayashi et al., 2005). Once PRDM9 binds at a hotspot, the SET domain allows PRDM9 to trimethylate
both histone H3 trimethylation on Lysine 3 (H3K4me3) and histone H3 trimethylation on Lysine 26
(H3K36me3) (Buard et al., 2009; Sun et al., 2015; Powers et al., 2016), a combination of marks that is
unique to hotspots. These epigenetic modifications at hotspots by PRDM9 subsequently may play a part
in allowing proteins like SPO11 to bind the hotspot and create meiotic DSBs necessary for synapsis
(Romanienko and Camerini-Otero, 2000; Diagouraga et al., 2018).
2.2. Homologous recombination is necessary for the progression of meiosis
Progression of meiosis starts in leptotene stage when Prdm9 is expressed and activates hotspots. Next is
zygotene stage where DSBs occur and homology search is initiated. Then in pachytene stage synapsis is
completed between homologous chromosomes and DSBs are resolved by homologous recombination.
Progression from zygotene stage into pachytene stage is particularly sensitive to completion of synapsis
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and repair of DSBs. Meiotic recombination plays essential roles in promoting the recognition, pairing,
and accurate segregation of homologous chromosomes (Hunter, 2015). In the absence of PRDM9, DSBs
are relocated to other sites marked by H3K4me3, “default sites” of PRDM9-independent H3K4me3,
including a large proportion of transcription promoters and enhancers (Brick et al., 2012). For unknown
reasons these DSBs are not efficiently repaired, leading to incomplete synapsis and meiotic arrest at
pachytene stage resulting in cell apoptosis (Hayashi et al., 2005).
2.3. Evidence suggests hotspots are sites of open chromatin
The question of whether open chromatin plays a role in hotspot activation and recombination began
with Dr. Christopher Baker’s observation (Baker et al., 2014) of multiple histone marks associated with
open chromatin at meiotic hotspots and evidence of nucleosome reorganization at active hotspots.
Some of these histone marks are deposited by PRDM9 when it binds to hotspots, like H3K4me3 and
H3K36me3. Additional active marks including H3K9ac and H3K4me1 are deposited by yet unknown
factors (Spruce et al, 2020). The presence of activating histone marks led us the question whether
nucleosome remodeling is also occurring to open chromatin at hotspots. Additional strong evidence of
induced MNase sensitivity at hotspots upon presence of PRDM9 (Baker et al, 2014), and DNase
hypersensitivity at a single specifically queried hotspot site (Shenkar et al., 1991) suggest DNA is made
accessible at activated hotspots.
2.4. Description of HELLS protein and expression
HELLS, encoded by the Hells gene, (and also known as Lsh, PASG, or SMARCA6) is a chromatin
remodeling protein in the SNF2 family (Jarvis, Geiman et al., 1996). SNF2 proteins are part of the
SWI/SNF complex that remodels nucleosomes in an ATP-dependent manner to increase accessibility of
DNA (Becker and Horz 2002). The HELLS protein contains seven conserved helicase domains (Jarvis,
Geiman et al., 1996) and an ATPase-domain (Ren, Briones et al., 2015, Jenness, Giunta et al., 2018). Hells
CKO mice are embryonic lethal, however not all SNF2 homologues share this phenotype (Essers,
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Hendriks et al., 1997, Reyes, Barra et al., 1998, Wesoly, Agarwal et al., 2006), indicating a specific role
for Hells in early development. Hells is expressed in undifferentiated ES cells, however it is significantly
downregulated in differentiating cells (Xi, Geiman et al., 2009). Hells expression was originally identified
in proliferating lymphocytes (Lsh – lymphoid-specific helicase) undergoing VDJ recombination (Jarvis,
Geiman et al., 1996), and is correlated with poor T lymphocyte proliferation (Geiman and Muegge 2000).
Poor proliferation is also a phenotype in neural stem/progenitor cells, which show a 60% decrease in
replication efficiency in Hells CKO (Han, Ren et al., 2017), and oogenesis and spermatogenesis, which are
completely arrested in Hells CKO (De La Fuente, Baumann et al., 2006, Zeng, Baumann et al., 2011).
2.5. HELLS protein functional activities
Previous studies have shown different roles for HELLS depending on its binding partner. For instance,
HELLS can remodel nucleosomes in complex with a DNA binding partner CDCA7 in zebrafish (Jenness,
Giunta et al., 2018), but cannot load onto chromatin or remodel nucleosomes in absence of CDCA7.
HELLS interacts with yH2AX at DNA double-strand breaks and is required to phosphorylate yH2AX which
is critical for efficient repair of DNA damage after ionizing radiation (Burrage, Termanis et al., 2012).
HELLS participates in classical non-homologous end joining in HEK293 cells with DNA-binding protein
CDCA7 (Unoki, Funabiki et al., 2018). HELLS is required for proper nucleosome density and de novo DNA
methylation by remodeling nucleosomes through its ATPase-domain (Ren, Briones et al., 2015, Termanis
et al., 2012, Torrea et al., 2016). DNMT3A/B de novo DNA methylation is dependent on HELLS
interaction with DNMT3A/B, resulting in a 30-50% reduction in DNA methylation in Hells CKO mice,
primarily at repeat regions (Dennis, Fan et al., 2001). Reduced methylation in these normally
heterochromatic regions leads to deregulated expression of certain transposable elements and
disrupted lamin B attachment (LADs) (Yu, McIntosh et al., 2014). These data suggest that the presence
of HELLS is necessary to allow certain cell processes that are dependent on chromatin compaction.
2.6. Hells phenotypes
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In female meiosis, Hells CKO oocytes fail to complete meiosis and arrest at pachytene stage due to
incomplete synapsis (De La Fuente, Baumann et al., 2006). The same phenotype was shown in male
germ cells during spermatogenesis where deletion of Hells leads to meiotic arrest at pachytene stage
and infertility (Zeng, Baumann et al., 2011). In embryonic cells, Hells expression is necessary for the
establishment of de novo DNMT3A/B -dependent DNA methylation to silence retroviral genes and
methylate endogenous genes (Zhu, Geiman et al., 2006). Altered chromatin structure due to global
demethylation in Hells CKO fibroblasts causes reduced proliferation through failed chromosome
segregation during mitosis (Fan, Yan et al., 2003, Sun and Arceci 2005). These phenotypes all show a role
for Hells in creating the necessary epigenetic environment for cell-specific functions. Given the fertility
phenotypes associated with Hells and our prior knowledge that epigenetic landscape at hotspots is
critical for hotspot activity, we set out to investigate the potential role of DNA accessibility at hotspots
and the potential role of the nucleosome remodeling protein Hells.
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CHAPTER 3
ATAC-SEQ ASSAY FOR OPEN CHROMATIN
3.1. ATAC-Seq is a new assay to interrogate regions of open chromatin
Increased DNA accessibility can lead to increased protein binding and many potential biological activities
and is often associated with actively transcribed DNA. Assay for Transposase Accessible Chromatin using
sequencing (ATAC-seq) uses direct transposition and ligation of DNA adapters compatible with highthroughput sequencing into native chromatin through a modified transposase that can access and cut
open chromatin (Buenrostro et al., 2013). The DNA adaptors allow PCR amplification to create a library
of DNA fragments compatible with sequencing on the Illumina platform. This greatly increases efficiency
and minimizing processing steps that lead to loss of product as compared to traditional sequencing
library preparation.
3.2. Determine optimal sample prep for ATAC-Seq
We optimized ATAC-Seq in our hands by performing preliminary testing on mouse embryonic stem cells
(mESCs) because they are easy to grow, tolerant to cryopreservation, and are the focus of another ongoing study in our lab. The published ATAC protocol was performed on extracted nuclei, so our plan was
to optimize a nuclear extraction protocol for our cells. However, the three methods we tried: a threedensity sucrose gradient layered column, a single sucrose gradient, and a commercially available
iodixanol gradient solution, all had very poor yields of purified nuclei and we realized it would be
difficult to impossible to collect enough spermatocyte cells from a fresh prep of 12-12dpp male testis to
get enough purified nuclei for the ATAC protocol. Therefore, we additionally performed the ATAC
protocol on intact fresh mESCs, avoiding nuclear purification altogether, and instead briefly lysing the
cells before adding Tn5. We also performed ATAC on cryopreserved mESCs (80% media, 10% FBS, 10%
DMSO, cooled at -1°/min to -80°), realizing there would be a huge advantage to having all samples
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collected and frozen before performed ATAC in one batch, instead of performed ATAC one by one on
each fresh sample. In the end, we tested three cell conditions: fresh intact cells, purified nuclei, and
cryopreserved cells.
3.3. Description of ATAC Tn5 mode of action
Tn5 is a hyper-active transposase loaded with forward or reverse primers. The ATAC protocol is
straightforward: Tn5 transposase is added to the cells where it diffuses into the nucleus.
Heterochromatinized regions of DNA are resistant to Tn5, but relaxed regions of chromatin like those at
regulatory regions are vulnerable to Tn5 transposase activity. Once in contact with exposed,
nucleosome-free DNA, the Tn5 makes a single-stranded cut and ligates an adaptor on the cut strand (Fig.
1A). The Tn5 must cut in two locations to liberate a DNA fragment from a nucleosome-free region.
Nucleosomes are an octamer of histone proteins wrapped with ~140bp of DNA, with ~60bp of linker
DNA between nucleosomes, so the DNA fragments liberated by Tn5 represent intranucleosomal, di-, and
tri-nucleosome DNA lengths because the Tn5 can only access the DNA where it is NOT bound by
nucleosomes. Additionally, Tn5 ligates adaptors onto the ends of DNA that are subsequently used to
amplify the DNA fragment during PCR amplification.
3.4. Description of library amplification of ATAC samples
We started by using mouse embryonic stem cells (ESCs) for our initial ATAC trouble-shooting, because
they are readily available and easily scalable. I used the original Greenleaf protocol (Wu et al., 2013) and
the Tagmentation enzyme kit from Illumina (cat #20034198). The amount of DNA obtained after Tn5
cuts at open chromatin regions is quite small and needs to undergo PCR amplification before there is
enough DNA product for sequencing. For sequencing library preparation, I used primers designed by the
Greenleaf lab that include an Illumina adaptor sequence, a barcode, an Illumina primer, and a Tn5
adaptor sequence (Fig. 1B). Each part of the library primer performs a function to allow the DNA
fragment to be sequenced. The Illumina adaptor sequence is complementary to the sequence on the
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Illumina sequencing flowcell, it attaches the fragment of DNA to the flowcell and allows it to be
amplified to make clusters. The barcode is a unique 8 base pair DNA sequence different between each
primer. When individual ATAC samples are amplified with different barcodes for each ATAC-Seq library,
the resulting libraries are pooled and the unique barcode sequence is used to demultiplex sequenced
samples that are sequenced together on the same flowcell. The Illumina primer is complementary to the
primers used in the NextSeq to initiate the sequencing reaction. Finally, the Tn5 adaptor sequence is
complementary to the adaptor ligated onto the DNA by Tn5 and serves as the binding sequence to
amplify the DNA fragments cut by Tn5. I used a PCR amplification program with 98°C denaturing step for
10 sec, 60°C primer annealing step for 30sec, and 72°C polymerase extension step for 1 min and
repeated these 3 steps for 8-12 cycles. PCR amplification both increases the amount of starting DNA and
adds the needed adaptors and barcodes to the DNA fragments.
3.4.1 Library PCR amplification considerations
The final library is sensitive to both over- and under-amplification by PCR. Too many cycles of PCR
amplification can randomly over-amplify some sequences over others, undermining library diversity and
resulting in duplicate fragments getting sequenced. On the other hand, too few cycles of amplification
will not yield enough product for downstream sequencing. The Greenleaf protocol recommends
performing quantitative PCR on a fraction of the library to determine the optimal number of
amplification cycles. After 4 cycles of PCR amplification, I removed the reaction and removed a 5 µl
aliquot from the total 50 µl reaction of amplified library to use in a separate qPCR reaction to determine
the additional number of cycles needed. I used the 5 µl of pre-amplified library in a 15 µl qPCR reaction
with SYBR green, and cycled 20X using the same amplification program. To maximize capture of the
ATAC DNA fragments and avoid over-amplification of PCR duplicates, the optimal amount of library
amplification is to stop the PCR at the transition to exponential amplification, as determined by the
qPCR curves. For the most part, our samples required ~9-10 total cycles of library amplification (Fig. 1C),
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which is exactly in the 8-12 cycle range recommended in the protocol. Samples requiring more cycles
than this would indicate low starting levels of DNA and increased PCR duplication rate, both of which
negatively affect the quality of sequencing results.
3.4.2. ATAC library purification
After completing library amplification, I purified the libraries using AMPure beads (Beckman Coulter
#A63880). These are magnetic beads coated with carboxyl molecules that reversibly bind DNA in the
presence of the “crowding agent” polyethylene glycol (PEG) and salt (20% PEG, 2.5M NaCl is optimal).
PEG causes the negatively-charged DNA to bind with the carboxyl groups on the bead surface. The
amount of DNA bound is dependent on the concentration of PEG and salt in the reaction, where adding
more beads allows more of the smaller fragments to be bound and less beads captures only larger
fragments of DNA. We experimented with using a two-step AMPure purification to exclude large
fragments and small fragments. Large DNA fragments (>600bp) do not form clusters on the sequencing
flowcell and therefore are not useful. Small fragments (<150bp) are mostly library primer dimers, and do
not have any meaningful sample DNA sequence. To exclude these, we added a 1:1 ratio of AMPure
beads to ATAC DNA library and then discarded the beads bound to large fragments. Then we added a
1.7:1 ratio of beads to library and kept the beads while discarding the supernatant containing small
fragments. After purification, BioAnalyzer was used to analyze library size and quantity.
3.4.3. ATAC library QC
The BioAnalyzer is a chip-based capillary electrophoresis machine to analyze RNA, DNA, and
protein. We use Bioanalyzer to look at fragment size and quantity in our sequencing libraries. The
BioAnalyzer results also showed that our ATAC libraries had distinct banding patterns indicative of
nucleosome organization (Fig. 1D). We see in our BioAnalyzer results a population of smaller-sized DNA
fragments that contain intranucleosomal fragments, then another population of fragments ~140bp
larger, and another population ~140bp after that. These successive peaks represent DNA fragments that
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were cut on either side of the nucleosome they occupied, liberating either mono-, di, or tri-nucleosome
fragments. The presence of this banding pattern also indicates that the chromatin was still intact when
we performed ATAC, a good indicator of quality. We found through experimentation that the dual size
selection was not worthwhile because we lost product during the two-step process and the large
fragments do not seem to interfere with the quality or quantity of our sequencing. We kept the 1.7:1
AMPure purification, and although there is still a population of primer dimer that is not removed, we did
not see evidence of these short sequences in our data. We did not want to increase the AMPure bead
ratio to eliminate the primers and risk losing smaller fragments that contain valuable sample DNA
sequence.

Figure 1. Description of ATAC assay. (A) Tn5 transposes cuts and ligates an adaptor on accessible DNA
(Buenrostro et al., 2013). (B) Library amplification adds barcodes and adaptors for sequencing
(Shashikant and Ettensohn, 2019). (C) Optimal PCR cycles for ATAC library are calculated from start of
qPCR exponential amplification. (D) BioAnalyzer traces show nucleosome banding in quality ATAC
libraries. (E) Comparison of ATAC peaks from fresh vs. frozen cells.
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3.5. Sequence analysis of ATAC samples
We sequenced the ATAC libraries from 8 experiments to determine the quality of the experiments and
enrichment for open chromatin regions. Initially we sequenced to a depth of 80-100 mln reads per
sample, paired-end reads, 75bp each. The resulting sequence files (i.e. fastq files) I ran through FastQC
to look for red flags in sequencing quality, over-represented sequences, and duplication rate. Overall,
the sample sequences passed quality criteria. There were some flags for adapter content at the 3’ end of
reads and for duplication rate that stood out. Other than that, there were flags for per base sequence
content at the 5’ end of reads, likely part of the library amplification process and Kmer content, which
commonly flags samples that are fine and is not part of the FastQC program in subsequent versions.
I used the Burrows-Wheeler Alignment tool (BWA) (Li and Durbin; 2009) to efficiently align short
sequencing reads against a large reference sequence, allowing mismatches and gaps. For my data, I used
the ‘bwa mem’ command to map the 75 bp ATAC-Seq reads to the B6 mouse genome (mm10). Next I
sorted the mapped reads into chromosomal order and convert the file into a compressed bam file using
‘samtools sort’ and samtools view’ (Li et al; 2009). I checked the number of reads mapping to each
chromosome and proportion of reads mapping to mitochondrial sequences using ‘samtools idxstat.’ To
check library complexity and estimate the number of unique reads I used Picard tools ‘MarkDuplicates’
to identify duplicate reads. These are reads from separate clusters on the flowcell but represent the
same starting DNA fragment that was amplified by PCR to make many copies. I removed all but one of
each duplicated fragment, because the copies represent the same biological instance and are not new
occurrences. We next used a Greenleaf lab script to shift our single-end mapped reads. If the read is on
the positive strand (as determined by the sam flag) it will add 4bp to the start and subtract 5bp from the
partner start. The reads are shifted because the Tn5 enzyme has a 9bp binding site, so the DNA must
have been open 4.5bp on either side of the integration, therefore by shifting the reads we are more
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accurately placing the open chromatin. This same script removes low quality reads and mitochondrial
reads. The output of these metrics is in Table 1.
3.6. Identification of unmapped reads
Immediately we noticed a depressed rate of mapped reads (Table 1). Looking closer at the sequence
identity of the unmapped reads we found sequence fragments originating from the Tn5 adaptors and
Illumina primers and adaptors. This can be explained if we imagine small fragments
of sample DNA being sequenced through their entire length and into the primer and adaptors sequences
on the 3’ side. The presence of the engineered sequence prevents alignment to the mouse genome
which lacks this sequence, even though part of each sequence contains mouse DNA. This issue we
resolved by using Trimmomatic ILLUMINACLIP:/opt/bin/Trimmomatic-0.39/adapters/NexteraPEPE.fa:2:30:10 LEADING:3 TRAILING:3 SLIDINGWINDOW:4:15 MINLEN:36 and specifying Nextera PE
adaptors to remove the Illumina sequences and everything after, which includes the Tn5 adaptor
sequence. Once the reads were trimmed, our alignment rate went back up to 97-100% (Table 1).
3.7. Call ATAC open chromatin peaks using MACS
To identify regions of open chromatin, pile-up of unique sequencing reads after alignment indicating
open chromatin (i.e., peaks), was performed using MACS (Zheng et al., 2008) with the command
‘macs14 -t <ATAC.bam> -f BAM -g mm -p 1e-5.’ MACS identifies peaks based on significant accumulation
of reads over the local background. I set the significance level at 1e-5 to filter for peaks that are clearly
and strongly enriched over the background, excluding less significant peaks that could be due to noise or
are barely measurable and therefore are unlikely to be biologically significant. At this threshold I
recovered ~80,000-170,000 peaks per sample (Table 1). I calculated the proportion of reads that were
counted in a peak compared to the total number of reads. This measurement of the fraction of reads in
peaks (FRiP) usually serves as a quality test for the specificity of the assay, where more reads in peaks is
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a more specific assay, vs high background and low FRiP. The ATAC-Seq I performed had the highest FRiP
and therefore sensitivity in the fresh mESC samples.
3.8. Trouble-shooting ATAC-seq protocol to reduce MT reads
One of the well-known issues with sequencing ATAC-Seq libraries is contamination with mitochondrial
DNA reads (Corces et al., 2016). In our samples, almost 40-50% of reads were mitochondrial (Table 1).
Since only chromosomal reads are informative, this represents a significant loss of sequencing capacity
and additional cost. One way to reduce mitochondrial read in ATAC-Seq data is to extract nuclei and
purify them away from the mitochondria. We had success in reducing the mitochondria by purifying
nuclei, but the cost was a huge reduction in yield, where we lost 75-95% of the nuclei during the
purification process. In order to reduce the number of reads lost to mitochondrial DNA, I tested a newly
published ATAC method called FastATAC, which was designed to reduce mitochondrial contribution. The
FastATAC protocol skips cell lysis, and instead permeabilizes the cells with digitonin, a detergent that
solubilizes lipids like those in cell membranes, making them more permeable. This allows the Tn5 to
access the chromosomal DNA while minimizing the lysis of the membrane-bound mitochondria. Using
the same number of ES cells but following the FastATAC protocol, we were able to reduce the
mitochondrial percentage from 40-50% to 5-10%. This resulted in an increase in the number of usable
chromosomal reads and allowed us to recover equal numbers of ATAC peaks from a sequencing depth
of 50-60 mln reads per sample compared to 100 mln reads per sample with the previous protocol
greatly reducing sequencing costs.
3.9. Nuclear extraction or fresh cells are not necessary for successful ATAC-Seq
Interestingly, the ATAC-Seq worked as well or better in intact cells vs nuclei and frozen vs fresh cells.
Although nuclei had fewer mitochondrial reads, the number of peaks called was reduced and the
fraction of reads in peaks was significantly lower than either fresh or frozen intact cells (Table 1). This
suggested that the process of purifying nuclei has an adverse effect on the integrity of the chromatin.
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Surprisingly, freezing cells and then thawing them for ATAC did not seem to impact assay quality in
terms of # peaks and FRiP (Table 1). To confirm that the peaks I was collecting from the frozen cells were
the same locations and relative intensities, I used the DiffBind analysis package(Ross-Innes et al., 2012)
which includes functions to overlap and merge peaksets, count sequencing reads overlapping intervals
in peaksets and identify statistically significantly differentially bound sites based on evidence of binding
affinity (measured by differences in read densities). I used the ‘dba.peakset’ command to collate a
consensus peakset for the fresh and cryopreserved frozen samples, and then ‘dba.count’ compare
normalized read counts falling within those peaks. The resulting MA plot shows fresh and frozen
samples have similar read counts in each peak, shown in black, and only ~7% of peaks are significantly
different at FDR <0.01, shown in red and blue (Fig. 1E). Although the similar results for fresh and frozen
mES cells may be cell type-specific, it is reassuring to think that samples could be collected for a project
over time, and then then assayed for ATAC all at once to minimize effort and batch effects.

Table 1. ATAC sequence analysis comparing fresh, frozen, or extracted nuclei conditions.
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CHAPTER 4
OPEN CHROMATIN AT HOTSPOTS IS DEPENDENT ON PRDM9 AND INDEPENDENT OF
DOUBLE -STRANDED BREAKS
4.1. ATAC-Seq on spermatocytes to look for open chromatin at hotspots
Based on the presence of histone marks that suggest open chromatin (H3K4me3, H3K36me3) and
increased MNase sensitivity at hotspots, we tested whether activated hotspots are sites of open
chromatin using ATAC-Seq. To investigate hotspot dynamics during male meiosis, we need to capture
leptotene/zygotene (L/Z) stage spermatocytes when PRDM9 is active. Previous research has shown that
the first wave of spermatogenesis in male mice is relatively synchronous and passes through L/Z stage at
~12-14 days post-partem (dpp) (Ball et al., 2016). At this time point, the mouse testes are enriched for
L/Z stage spermatocytes, increasing the chances of capturing activated hotspots and minimizing
background from non-meiotic cells.
4.2. Sample choice for spermatocyte ATAC-Seq
Before performing ATAC-Seq on 12dpp spermatocytes, we needed appropriate controls in order to
decisively conclude the signal we might find at hotspots was truly meiosis- or PRDM9-specific. We can
take advantage of a genetically-modified knock-in mouse with a different allele of PRDM9. The knock-in
mouse, B6-PRDM9CAST-KI/Kpgn (B6CAST-KI, Baker et al., 2014), has the same genetic background as
C57BL/6J with the exception of the PRDM9 zinc-finger domain, which is from the CAST/EiJ Prdm9 allele.
The zinc-finger domain for PRDM9Cst has both different numbers of and different identity of zinc-fingers
resulting in a protein variant that recognizes and binds different DNA sequences. Therefore, we expect
that meiosis-specific open chromatin at hotspots will differentially appear at allele-specific sites for B6
PRDM9Dom2 and the CAST PRDM9Cst , while all other open chromatin sites should stay the same. We
performed ATAC-Seq on two replicates each B6CAST-KI and B6 12dpp spermatocytes.
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4.3. Spermatocyte isolation and transposition
To extract spermatocytes from the 12dpp testes, I used the established protocol for isolating
spermatocytes for chromatin assays (Baker et al., 2014) and applied it to the ATAC-Seq protocol. Briefly,
I collected testes from 12dpp male mice into HEPES-buffered DMEM and disaggregated them using a
collagenase-based dissociation with Liberase TM (Sigma, cat# 5401119001). After two 15min
incubations at 37° with Liberase TM, the tubules become fragmented by enzymatic digestion, and I
further reduced them to single cell suspension by pipetting them vigorously 50X with a 10mL serological
pipet. After filtering for single cells using a 40um filter and washing with PBS, I put the spermatocytes
straight into the FastATAC protocol, using 100,000 spermatocyte cells per reaction.
4.4. ATAC-Seq data from spermatocytes shows good nucleosome banding and enrichment at TSS’s
After sequencing and processing the data with the workflow we established for ATAC-Seq, I performed
further quality control tests looking at correlation between replicates, insert size metrics, and read
coverage over TSS’s. To calculate correlation between the replicates, I used DiffBind to obtain a shared
peakset and normalized reads, then plotted a scatter plot of normalized rpms for each peak. The
correlation within replicates was excellent, Pearson’s r=0.96 for the B6 replicates and r=0.99 for the
B6CAST-KI replicates (Fig. 2A, B6 shown). To examine DNA fragment lengths showing nucleosome
occupancy, I ran Picard ‘CollectInsertSizeMetrics’ which outputs a histogram of read lengths for each
sample. The insert size metrics for our ATAC libraries show a large proportion of reads with less than 100
bp, which represents the nucleosome-free regions, and then fragment size periodicity corresponding to
the approximate lengths of DNA wrapped around nucleosomes, indicating nucleosome occupancy from
quality, intact chromatin (Fig. 2B).
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Figure 2. ATAC-Seq shows open chromatin at hotspots. (A) ATAC-Seq replicates on B6 spermatocytes
show high correlation. (B) ATAC-Seq read length show evidence of nucleosome banding. (C) ATAC
reads are enriched at transcription start sites (TSS’s) (D) ATAC reads are enriched at hotspots. (E)
ATAC and PRDM9 read depths across a 2kb region centered on hotspots for 7,233 hotspots. (F)
Density plot of aggregate signal over hotspots for both ATAC and H3K4me3.

Another hallmark of quality ATAC-Seq data is enrichment of reads at transcription start sites
(TSS’s), where active chromatin at gene promoters are known to have open chromatin. I used
CoverageView to inspect how the ATAC-Seq coverage distributed across the genome (Lowy, 2020), and
specifically to plot read coverage profiles around TSS’s. I used as input our ATAC bam files and a bed file
of ENCODE-curated TSS’s and ran CoverageView ‘cov.matrix’, and the program returned a matrix with
read counts at each base pair location across the 2 kb region centered around each TSS. I plotted the
means in a density plot to look at enrichment of ATAC reads and our libraries show a strong peak at the
TSS that quickly tapers on either side to background levels, showing specificity. Our ATAC-Seq showed
an enrichment of ~14-20 rpm at TSS’s compared to <1 rpm in the flanking regions (Fig. 2C, B6 shown).
Our enrichment at TSS’s was within the range recommended by ENCODE, which suggests a TSS
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enrichment of 10-15 is acceptable, and >15 is ideal (https://www.encodeproject.org/atac-seq, updated
June 2020)
4.5. ATAC peaks at hotspots show increased DNA accessibility during meiosis
I recovered 88,474 shared ATAC peaks from the B6 spermatocyte samples. I annotated the peaks based
on whether they overlapped with known TSS’s, PRDM9Dom2-hotspots, or other. In addition to open
chromatin at promoters, our spermatocyte samples had ATAC peaks that overlap hotspots, confirming
that hotspots are sites of open chromatin. Of 7,223 hotspots for which we know PRDM9 motif location ,
I recovered 1,527 by ATAC-Seq. Although this overlap is low, I am likely over-looking low-level ATAC
peaks at hotspots due to my stringent peak-calling (e-5), lower signal at hotpots due to heterogenous
cell types and assorted hotspot usage within meiotic cells, and the more limited dynamic range of the
ATAC assay. I tested for enrichment for ATAC reads at all hotspots by plotting normalized reads per
million from ATAC (rpm) using hotspot PRDM9 motifs as the center of a 2kb window. There is clear pileups of ATAC reads at the hotspot centers compared to the flanking regions (Fig. 2D). A heatmap of the
CoverageView matrix shows ATAC enrichments at individual hotspots, where the strongest hotspots
from PRDM9 ChIP have the strongest ATAC signals (Fig. 2E). Though the largest ATAC signal is in the
middle of the hotspots, there are secondary small peaks on either side that correlate with strict
nucleosome remodeling around hotspots. Overall, these results confirm our hypothesis that hotspots
are regions of open chromatin specific to the hotspot site.
4.6. Hotspots show differential DNA accessibility dependent on PRDM9 allele
To compare peaks between different samples, I concatenated the peak sets from all samples and then
merged overlapping peaks with BEDTools (Quinlan and Hall, 2010) using ‘bedtools merge’ to make a
shared “peakome.” This allowed me to standardize my analysis by using the same peaks for every
sample. Using bedtools ‘multicov,’ I counted reads from bam files for each sample that map to the
peakome. I then used edgeR (Robinson et al., 2010) to investigate differential expression of count data

18

from different samples. edgeR uses an overdispersed Poisson model to account for both biological and
technical variability and correctly identify true differences and minimize background (Robinson et al.,
2010). I used ‘calcNormFactors’ to produce a matrix of normalized read counts per peak for each
sample. I filtered for peaks with less than 3 reads to minimize low-level and sample-specific peaks that
skew statistical analysis. I used this normalized peak matrix to test for differential ATAC peaks between
B6CAST-KI and B6.
I plotted an MA plot to determine the change in ATAC peak accessibility between the two
strains. The MA plot showed that most ATAC peaks did not change between the two strains of mice,
which would be expected since the mice have the same genetic background (Fig. 3A). However, there
was another set of ATAC peaks that showed significantly different DNA accessibility, and these locations
correspond to hotspots that are determined by either PRDM9Dom2 (blue) or PRDM9Cst (red). I uploaded
bedgraph tracks for each of the ATAC-Seq samples to the UCSC genome browser to visualize ATAC reads
along the genome. I looked at allele-specific hotspots and confirmed that the B6CAST-KI showed no DNA
accessibility at PRDM9Dom2 hotspots but did have novel DNA accessibility at PRDM9Cst hotspots compared
to B6 (Fig. 3B). For the ATAC peaks that were significantly higher (FDR<0.01) in the B6CAST-KI, 92% (n =
5,305) overlap with reported PRDM9Cst-dependent hotspots (Baker et al., 2014). Reciprocally, for the
ATAC peaks that are higher in B6, 94% (n = 1,643) overlap PRDM9Dom2-dependent hotspots (Baker et al.,
2014). The difference in the number of ATAC-enriched hotspots detected in the B6CAST-KI vs the B6 is due
to PRDM9Cst having stronger binding affinity in the B6 genetic background than the endogenous
PRDM9Dom2, which has been previously published (Baker et al., 2014; Baker et al., 2015a; Baker et al.,
2015b; Grey et al., 2017). Clearly, hotspots are sites of PRDM9-specific open chromatin
4.7. Open chromatin at hotspots is independent of double-stranded breaks
An alternative explanation for open chromatin at hotspots is the presence of double stranded DNA
breaks (DSBs). It is known that DSB repair machinery can remodel nucleosomes and create DNA
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accessibility to facilitate DNA repair (Price and D'Andrea, 2013). In meiosis, hotspots become sites of
programmed DSBs after PRDM9 binds and the DNA is cut by meiosis-specific SPO11 (Baudat et al., 2000;
Romanienko and Camerini-Otero, 2000). Therefore, we investigated whether the appearance of
increased DNA accessibility at hotspots is due to meiotic DSBs or happens in the absence of DSBs.

Figure 3. Open chromatin at hotspots is dependent on PRDM9 binding and independent of DSBs. (A)
MA plot of differentially open chromatin peaks between B6 and B6 CAST-KI with known hotspots for
each allele in color. (B) Bedgraph pile-ups of ATAC reads from B6 and B6CAST-KI ATAC-Seq over a
Prdm9Cst and a Prdm9Dom2 hotspot. (C) MA plot of differentially open chromatin peaks between
Spo11 KO and WT. Hotspots are highlighted in red.

4.8. ATAC-Seq on Spo11 mutant mice shows open chromatin at hotspots
We used a knock-out mouse with an inactive allele of Spo11 (B6.129X1-Spo11tm1Mjn/J) (Baudat et al.,
2000) and performed ATAC-Seq to look for open chromatin hotspots before DSBs by SPO11. Since
SPO11 is catalytically dead and does not make DSBs, any open chromatin at hotspots in the Spo11
mutant will be independent of DSB repair machinery suggesting it is dependent on PRDM9. Indeed,
when I compared ATAC-Seq peaks from 12dpp Spo11 mutant to wildtype littermates, there were no
differences in ATAC peaks, including at hotspots (Fig. 3C). Therefore, open chromatin at hotspots exists
prior to and independent of SPO11 double-stranded breaks.
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CHAPTER 5
HELLS AND PRDM9 ARE CO-EXPRESSED IN L/Z OF MEIOSIS AND FORM A PROTEIN COMPLEX
5.1. HELLS is a good candidate for meiotic chromatin remodeling
Above I showed that hotspots are sites of open chromatin and that open chromatin at hotspots is
dependent on PRDM9. Although PRDM9 can bind DNA and modify histone marks at hotspots, it lacks
the domains for nucleosome remodeling. If there is another protein creating open chromatin at
hotspots, like we hypothesize, then loss of that protein should show an infertility phenotype similar to
loss of PRDM9. We examined mouse phenotypes in mice with mutations in known chromatin
remodeling proteins and found three candidates with a fertility phenotype: Brg1, Ino80, and Hells. We
further narrowed the candidates by looking for a fertility phenotype that mimics PRDM9 knockout
phenotype (Hayashi et al., 2005), specifically a block in early pachytene due to incomplete synapsis and
persistent DSBs. Loss of Ino80 (Serber et al., 2016) and Hells (Zeng et al., 2011) mutations exhibited
meiotic infertility phenotypes similar to loss of Prdm9, however Ino80 is involved in H2A.Z and H2A
variant exchange (Papamichos-Chronakis et al., 2011), and previous work did not find evidence of H2A.Z
at recombination hotspots (Spruce et al., 2020). Given that HELLS is capable of remodeling chromatin
and creating DNA accessibility, and has a fertility phenotype, we sought to determine whether HELLS
can associate with PRDM9, particularly in spermatocytes in L/Z stage meiosis.
5.2. Hells RNA is expressed in meiotic spermatocytes
On indication that Hells would play a role in meiotic recombination would be it is expressed during
leptotene/zygotene stage spermatocytes, just like Prdm9. It would add strength to our hypothesis is
Hells expression is also specific to this stage over others. We searched for Hells RNA expression using
data from Jung et al., 2019 that performed single cell RNA-Seq on testes to define stages of
spermatogenesis. We saw strong expression of Hells in L/Z spermatocytes, which correlated with
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expression of Prdm9 (Fig. 4A and B). However, unlike PRDM9, Hells is additionally expressed in
spermatogonia at an earlier stage in spermatogenesis (Fig. 4B). As a side note, Ino80 is expressed during
meiosis, but more broadly and not correlated with Prdm9. This data shows that HELLS is present when
PRDM9 is acting to establish recombination hotspots and during the acquisition of meiotic DSBs.
5.3. Confirm HELLS protein expression in testis
Now that we know Hells RNA is expressed in L/Z stage cells, we wanted to confirm that HELLS protein
was indeed present, since RNA expression does not necessarily mean that the protein is being
translated. Commercial anti-HELLS antibody are available through several vendors. The rabbit polyclonal
anti-HELLS antibody from Millipore (cat# ADB41), was reported to work for Western blot and recognize
both mouse and human HELLS. To test whether the anti-HELLS antibody worked, I extracted protein
from mouse tissues that should be either positive (testis) or negative (heart and liver)for HELLS protein. I
took a ~10mg piece of tissue for each sample and used the previously published RIPA extraction
protocol to lyse the tissues and extract protein (Baker et al., 2015b). Samples were heated to 95°C for 5
min with 1X Laemmli’s buffer, which contains 1% SDS that helps denature and unfold proteins, allowing
them to run on the gel at their proper size and expose latent epitopes. I loaded the Invitrogen 4-12% gel
heavily with 60ug protein/lane to maximize my chances of seeing a signal I followed the manufacturer’s
recommended concentration of 1:5000 anti-HELLS antibody in our primary incubation conditions of TBS
+ 0.3% Tween, overnight, at 4°. The next day, I washed the blot and incubated it for an hour in 1:10,000
anti-rabbit secondary conjugated with horseradish peroxidase (HRP) and washed it again. I developed
the blot using SuperSignal™ West Pico PLUS Chemiluminescent Substrate (ThermoFisher Scientific,
34579), which provides the substrate to the HRP enzyme to produce luminescence. I exposed the blot
on film using at 1min, 30sec, 15sec, and 5sec intervals and then developed the film to look for signal at
97kD, the expected weight for HELLS.
5.4. Testis shows strong, specific signal for HELLS
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The testis sample showed strong, specific signal for HELLS around 110kD (Fig. 4D). In contrast, none of
the other tissues were positive for HELLS. The protein band for HELLS is higher than the calculated
weight, but both the manufacturer’s example Western and Westerns for HELLS from other papers both
show bands the same size as mine. Post-translational modifications, such as phosphorylation or
glycosylation, could cause the protein to run slower on a Western gel. I concluded from these
preliminary results that we could detect HELLS with our antibody, and I confirmed that HELLS is
specifically expressed in testis.
5.5. Immunohistochemistry on testis cross-sections shows co-localization of PRDM9 and HELLS in the
same cells
In addition to the positive results from the RNA-Seq and the western, we wanted proof that HELLS and
PRDM9 are co-expressed in the same cells. Immunohistochemistry is a technique to detect proteins of
interest in fixed tissue sections by fluorescently labeling them with modified antibodies.
5.5.1 Fixation of adult testis and mounting cross-section onto slides
Samples for immunohistochemistry are fixed to preserve the structure and cellular context of the tissue.
I fixed 6-week old adult C57BL/6J testis in 4% PFA overnight at 4°. The next day, I moved the fixed tissue
into 70% ethanol to wash away the fixative before submitting my sample to the Histology core where
the fixed testis was embedding in paraffin and cross-sectioned onto slides. I requested 5µm thick
sections spaced ~1 cm apart along the slide so I could perform multiple IHC assays on the same slide
without touching between sections.
5.5.2. Deparaffinization, rehydration, and antigen unmasking
Embedding the tissue in paraffin supports the tissue structure for fine sectioning but interferes with IHC
analysis. In addition, the sections need to be dehydrated to remove excess fixation solution and tissue
fluids that will interfere with the IHC reaction. Both of these are accomplished by washing twice for 8
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min in xylene, followed by 2 min washes in 100%, 95%, 80%, and 70% EtOH. I rinsed the slides for 5 min
in H2O and rehydrated them with three 5 min washes in PBS.
The process of sample fixation can lead to protein cross-linking, which masks antigens and can
restrict antigen-antibody binding. Antigen unmasking permits antibodies to access the target protein
within the tissue. To unmask antigens, I boiled the slides submersed in 10mM sodium citrate in the
microwave for 10 min to break protein cross-links and unmask antigens. Afterwards, I let them cool to
room temperature undisturbed before rinsing them three time for 5 min in PBS.
5.5.3. Permeabilization of cells and blocking of non-specific binding
IHC signals can be improved by increasing antibody access to cells by permeabilizing the cell membranes
with a detergent like Triton X-100. I incubated my slides in 0.05% Triton-X100 in PBS for 30 min at room
temperature to permeabilize, and then washed three times for 5 min in PBS. IHC signals can also be
improved by reducing background noise from antibody binding to non-specific targets. Normal donkey
serum (NDS)contains antibodies that do not recognize any mouse proteins. Therefore, any interactions it
forms to tissues are non-specific, and pre-emptively displace potential non-specific interactions with our
target antibody. I blocked my slides with 10% normal donkey serum in PBS for 30 min. I used a humid
chamber to inhibit evaporation and allow me to reduce the amount of reagent I needed for each
section. Instead of submerging the slide in 10% NDS, I circled each of my tissue sections with a
waterproof marking pen to restrict run-off, and then deposited a 30-50 µl droplet of blocking solution
into the circle and onto the section. After 30 min of blocking, I tilted the slide and tapped it gently to
knock off the droplets from the sections, and then added the primary antibody.
5.5.4. Titrating anti-HELLS IHC staining
First, I needed to ensure our anti-HELLS antibody worked in our IHC assay and determine the optimum
concentration of antibody. I based my anti-HELLS dilutions on the typical range of dilutions for IHC,
which was ~1:200 to 1:500 for most antibodies. I have 5 testis sections per slide, so I diluted the anti-
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HELLS antibody to 1:1000, 1:500, 1:250, and 1:100 in PBS + 1% BSA and kept one section as a secondaryonly control. I deposited 20-30 µl of primary antibody solution to each of the sections, and PBS + 1% BSA
only to the secondary-only control and incubated overnight in a humid chamber at 4°.
5.5.5. Addition of fluorescently-conjugated secondary antibody and imaging
The next day, I tapped off the primary antibody solution and submersed my slide in three 5min washes
in PBS. I re-blocked with 10% NDS for 15 min before adding the secondary antibody. Secondary
antibodies can be conjugated with several different fluorophores, and it is important to have a range of
fluorophore options to perform co-staining with multiple antibodies and not have the secondary
fluorophores overlap. I used goat anti-rabbit IgG, Alexa Fluor 488 conjugate (ab150077) to detect HELLS
at 1:300 in PBS + 1% BSA for 2 hrs. It is crucial to perform the secondary incubation in the dark to
protect the fluorophores from light. After secondary antibody incubation, I washed the slides and
mounted them with antifade reagent with DAPI. I imaged the slides with the Zeiss AxioImager and saw
strong, specific staining for HELLS in all four antibody dilutions, and nothing in the secondary-only
control. I chose 1:250 as the concentration, because it appeared to be the best balance between strong
staining and not overloading the signal.
5.5.6. Immunostaining with antibodies to HELLS, PRDM9 and marker protein yH2AX
The goal of my IHC staining was to confirm colocalization of PRDM9 and HELLS in the same cell. I
performed IHC on adult testis sections and co-stained for HELLS, PRDM9, and yH2AX. I included yH2AX
as a marker to help distinguish stages in spermatocytes. The yH2AX protein localizes to double-stranded
DNA breaks, therefore it stains strongly and diffusely in L/Z stage when DSBs are present due to SPO11
activity. In pachytene stage, yH2AX staining becomes restricted to the sex body. I used the optimized
concentration for anti-HELLS (1:250 Millipore/Sigma, ABD41) along with previously optimized
concentrations for anti-yH2AX (1:2000, Millipore 05636I, lot#2888552) and anti-PRDM9 (1:100,
Parvanov et al. 2017) and was careful to use non-overlapping fluorophores for each of my secondary
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antibodies (goat anti-rabbit IgG Alexa Fluor 594 conjugate (A-11037) 1:300, goat anti-mouse IgG Alexa
Fluor 647 conjugate (A-21236) 1:300, goat anti-guinea pig IgG Alexa Fluor 488 conjugate (A-11073)
1:300). I imaged the sections and saw clear, specific staining in each of my channels. The PRDM9 staining
was not as strong or specific as the others, I needed to increase the exposure time and accept some
non-specific signal in between the tubules. I tried trouble-shooting the protocol to increase PRDM9
signal but was not able to improve it. Still, within tubules it was clear which cells were positive for
PRDM9 and which were not, even if the staining was not as crisp as the other two antibodies.

Figure 4. Hells is co-expressed in testis with Prdm9. Single-cell RNA-Seq tSNE plot of (A) Prdm9 (B)
Hells (C) leptotene stage expression in spermatogenesis. (D) Western for HELLS of testis and various
other tissues. (E) Western for HELLS of immunoprecipitation (IP) using IgG or PRDM9 antibodies on
testis protein. (F) Immunohistochemistry (IHC) on adult testis sections staining for DAPI, HELLS,
PRDM9, and yH2AX.

The results clearly show co-staining of both HELLS and PRDM9 (Fig. 4F), showing that HELLS and
PRDM9 are active and expressed at the same time in the same cell. The co-stained cells appear to be L/Z
stage judging by the diffuse yH2AX signal. In addition, I could see HELLS signal in type B spermatogonia,
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which are pre-meiotic cells showing no yH2AX signal, and also in pachytene-stage cells, where both
HELLS and yH2AX are localized to the sex body. The immunohistochemistry results on testis sections
shows co-localization of HELLS and PRDM9 and support our hypothesis that the two proteins may
interact to activate hotspots in L/Z stage meiosis.
5.6. HELLS protein forms a complex with PRDM9 protein
HELLS has no DNA binding domain of its own and so likely needs to be tethered to a binding partner
with DNA-binding specificity to be recruited to DNA (Zhu et al., 2006; Jenness et al., 2018) . I performed
coIP for HELLS and PRDM9 to determine whether HELLS protein can form a complex with PRDM9
protein, which would provide a mechanism for HELLS recruitment to hotspots. Protein coimmunoprecipitation is a well-established technique to look for protein interactions. The technique
works by using a bead-bound antibody to bind and purify the primary protein and whatever protein
complex that is co-bound to it. Then a Western blot for the second protein of interest is run on the
purified protein material, to interrogate whether the two proteins form a complex that can be coimmunoprecipitated. Two working antibodies, one for each protein, are required for coimmunoprecipitation. Luckily, we were gifted a working PRDM9 antibody from a collaborating lab
(Parvanov et al., 2017).
5.6.1. Protein extraction to preserve protein-protein interactions for co-IP
For the co-immunoprecipitation, I extracted testes from four 12dpp mice and pooled them into one
sample to get enough protein for a negative control co-IP, HELLS experimental co-IP, and untreated
control protein. My previous protein extractions used RIPA buffer, which contains harsh detergents
good for lysing cells and denaturing proteins. However, for the co-IP I used HEPES extraction buffer (50
mM Hepes-KOH pH 7.4, 137 mM NaCl, 10% Glycerol, 0.4% NP-40) to minimize disruption of potential
protein complexes and keep them intact for pull down. I added benzonuclease to degrade DNA and
RNA. This is good for two reasons: to prevent clumping due to sticky DNA released from dying cells, and
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to avoid spurious interactions from co-binding at the same chromatin site, rather than true proteinprotein binding.
5.6.2. Co-IP experiment and controls
The goal of the co-IP experiment is to test whether HELLS and PRDM9 form a complex in L/Z
spermatocytes. I performed co-IP with anti-PRDM9 antibody to purify PRDM9 protein and any other
proteins associated with it. In addition, I also performed co-IP with anti-IgG antibody which has no
specificity to any protein and serves as a negative control to show non-specific background signal. First, I
incubated 4 µl of either anti-PRDM9 or anti-IgG with 20 µl of Protein G magnetic beads for >20 min to
bind the antibody to the beads. After washing to remove excess antibody, I added 40% of the testis
protein to each co-IP with HEPES buffer with protease inhibitors. The leftover 20% of protein I saved as
untreated input control. I incubated the co-IP overnight at 4° to allow the antibody to bind with its
target protein. The next day I placed the co-IP solution against a magnet to draw the antibody-beads out
of solution, and along with it the protein of interest and any co-bound proteins. I washed the away the
unbound protein fraction from the beads and then eluted the bound protein from the beads by adding
Laemmli’s buffer and heating to 95° for 10 min, allowing the SDS to simultaneously release the proteins
and linearize them.
5.6.3. co-IP for PRDM9 co-precipitates HELLS
To determine whether HELLS is concurrently pulled down in an IP for PRDM9, I ran the resultant co-IP
protein on a Western and blotted with anti-HELLS. The protein pulled down in the anti-IgG co-IP showed
no enrichment for HELLS, a confirmation of the assay’s specificity, however, the anti-PRDM9 co-IP
protein had a positive signal for HELLS, showing that the two proteins are in a complex together (Fig.
4E). The strength of the HELLS signal in the anti-PRDM9 co-IP was weaker than the total signal from the
untreated input protein, which could be due to either a weak bond between the two proteins that could
not hold up to processing, or not every molecule of the PRDM9 protein is bound to a molecule of HELLS
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protein. Still, the result of a co-IP is a qualitative rather than quantitative result and the positive
interaction is clear. This evidence of PRDM9 interacting with HELLS encouraged us to believe that if
PRDM9 binds to HELLS, it could be recruiting HELLS to hotspots.
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CHAPTER 6
CREATION OF A CONDITIONAL KNOCK-OUT OF HELLS IN MICE
6.1. Creation of a conditional knock-out mouse model to investigate loss of HELLS in vivo
In order to prove that Hells is the operative protein inducing DNA accessibility at hotspots, we needed to
inactive or remove it during meiosis and determine effect on chromatin. Unfortunately, homozygous
Hells null mice are not viable and die within a few hours of birth, probably due to liver problems
(Geiman et al., 2001). Previous labs had attempted to circumvent this by surgically grafting newborn
Hells KO testis cells into adult wildtype hosts (Zheng et al., 2011). Doing so they found a meiotic arrest at
pachytene in the Hells KO spermatocytes. To improve on the previous study and determine the
mechanism of the meiosis-specific functions of Hells in vivo we created a Hells conditional knock-out
(CKO) mouse.
6.1.1. Creation of mice from EUCOMM conditional KO mESCs
An international consortium generated conditional knock-outs alleles for of most mouse genes,
including Hells, so we did not need to design and construct a Hells KO allele de novo. We ordered
conditional Hells KO embryos from EUCOMM, C57BL/6NTac- Hellstm1a(EUCOMM)Wtsi/Ieg, EM04583. In the
case of the Hells allele, critical exon 12 is flanked by loxP sites (Fig. 5A). All conditional alleles from
EUCOMM follow the same structure: a 5’ intronic integration upstream of a critical exon containing an
FRT-flanked cassette that contains lacZ and neo genes followed by one loxP site, and another intronic
integration containing just a loxP site on the 3’ side of a critical exon (Fig. 5B).
6.1.2. Genotyping pups from rederivation
The EUCOMM repository shipped frozen 2-cell embryos from a heterozygous C57BL/6NTacHellstm1a(EUCOMM)Wtsi/Ieg male by a wildtype female. We employed the Reproductive Services core at The
Jackson Laboratory to transfer the frozen embryos into pseudo-pregnant female B6 mice. The transfer
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was successful, and we received 16 pups that must be either heterozygous Hells-tm1a or wildtype. To
genotype the pups, I used the PCR assay provided by EUCOMM. The forward primer, Hells-5’arm-F, for
both the wildtype and mutant alleles is upstream of the 5’ integration cassette in wildtype sequence.
The reverse primer for the wildtype assay, Hells-3’arm-R, is 3’ of the integration site, and amplifies the
native sequence in the wildtype allele. However, in a mutant allele, the presence of the lacZ and neo
cassette will put the wildtype reverse primer too far away from the Hells-5’arm-F to amplify a PCR
product. The reverse primer for the mutant allele, LAR3-R, is located within the integrated cassette and
amplifies a product only when the conditional allele is present (Fig. 5B and C).
6.1.3. Removal of lacZ and neo cassette by mating to FLP
The Hells-tm1a allele that we currently had is a targeted trap allele with a splice acceptor upstream of
the lacZ gene. Left intact, the tm1a will interrupt proper splicing and generate a null allele. To remove
the cassette, I mated Hells-tm1a heterozygous mice to homozygous transgenic ACTFlpe mice that
constitutively express flippase recombinase protein (FLP) that will excise the DNA flanked by Frt sites,
leaving behind a single inactive Frt site. I genotyped the offspring from the ACTFlpe/ACTFlpe x Hellstm1a/+ mating using the common forward primer that sits just outside of the integration cassette, Hells3’arm-F, and the reverse primer I designed that sits 3’ of the lacZ neo cassette integration, Hells 3’
integration-R, and saw the smaller PCR product expected if the cassette was removed, indicative of FLPexcision. I also double-checked to be sure there was no Hells-tm1a allele remaining by genotyping with
the Hells 5’arm-F and the LAR3-R and saw no evidence of the tm1a allele. After crossing to FLP, the
tma1a allele was converted into tm1c, containing just the loxP-flanked Hells exon 12. I genotyped for the
Hells-tm1c allele using a primer that overlaps the 5’ loxP site, giving it specificity to the conditional allele,
with Hells 3’arm-R (Fig. 5C). This Hells-tm1c (“c” for conditional) allele is what I used in subsequent
matings.

31

Figure 5. Visual description of EUCOMM conditional allele and Hells CKO genotyping assays. (A) Overview
of Hells gene and integration of conditional knock out allele. (B) Cre mating scheme to generate
conditional knock out in testis. (C) Visual representation of elements in tm1a, tm1b, and tm1c alleles. (D)
Example gel showing bands from different genotyping assays.

6.1.4. Mating of Hells-tm1c to Stra8-iCre to generate heterozygous null and on-board Stra8-iCre allele
To improve my chances of a complete null, my strategy was to first ensure complete deletion of one
conditional allele, and then pursue cell type-specific deletion of the second conditional allele in only
spermatocytes. First, I made a constitutive heterozygous knock out of Hells by crossing Hells-tm1c to
Stra8-iCre. Heterozygous Hells mice are viable and fertile, with no overt phenotypes. My goal is to
completely delete Hells in L/Z stage spermatocytes, however Cre excision is not always completely
efficient. By completely excising one of the floxed exons, I will increase my chances of getting complete
excision of the one remaining floxed allele.
The Stra8-iCre mouse expresses iCre under control of the Stra8 promoter, which is expressed
specifically at the onset of meiosis in spermatocytes. Using Stra8-iCre is advantageous for two reasons:
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first, the Stra8-iCre is expressed in male germ cell development, so offspring from a Stra8-iCre; Hellstm1c sire will be constitutive Hells null for the conditional allele; second, the Stra8-iCre is specificallyexpressed in L/Z stage meiosis, which is critical for the second step when I will generate conditional Hells
null spermatocytes. By generating mice through these two matings, I can create a Hells conditional
knock out in testis while the rest of the animal remains heterozygous for Hells, as depicted in Fig. 5B.
I mated Hells-tm1c/+; ACTFlpe/+ mice to Stra8 iCre/+ to both breed away from the ACTFlpe
allele and gain the Stra8 iCre allele. I genotyped the offspring and looked for male pups that were
positive for Hells-tm1c and Stra8-iCre, and negative for ACTFlpe, which given the 50% probabilities of
each of these alleles make the combined probability of about 1/16th of all pups. The resulting male Hellstm1c; Stra8-iCre offspring will produce heterozygous null germ cells. The second generation indeed
genotyped positive for the deletion, becoming Hells-tm1d (“d” for deletion) (Fig. 5D).
6.1.5. Mating of Hells-tm1c/Hells-tm1c females to Hells-tm1d; Stra8-iCre males to produce the
genotype of interest
Meanwhile, I mated Hells-tm1c/+; ACTFlpe/+ mice to each other to produce homozygous Hellstm1c/Hells-tm1c females that were negative for ACTFlpe (1/32th probability). To obtain males that were
Hells null in L/Z spermatocytes, I mated Hells-tm1c/Hells-tm1c females to Hells-tm1c/+; Stra8-iCre/+
males (will be Hells-tm1d in germ cells) to produce offspring that are Hells-tm1c/Hells-tm1d; Stra8-iCre
males, the final genotype of interest. I maximized my chances of getting Hells-tm1c/Hells-tm1d; Stra8iCre males through this final mating, but still the probability is only 1/8th. The only way I could increase
my odds is by making the Stra8-iCre allele homozygous in the sire, which I was able to do in subsequent
matings by identifying Hells-tm1d; Stra8-iCre/Stra8-iCre males through progeny testing, given that the
generic iCre primers cannot differentiate between heterozygous and homozygous Stra8-iCre.
I genotyped the male offspring from my final cross for Stra8-iCre, Hells-tm1c, and Hells-tm1d.
The Hells tm1d allele I genotyped using the Hells 5’arm-F primer with Hells 3’ integration-R, which span
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the floxed exon. In the tm1c conditional allele, the primers are 1200 bp apart, but in the Hells-tm1d
excised allele, they are only 705 bp apart (Fig. 5C). I also genotyped for the maternal Hells-tm1c allele
and the paternal Stra8-iCre. In my genotype of interest, the mouse tail DNA will genotype as Hellstm1d/Hells-tm1c; however, in the spermatocytes the Stra8-iCre allele will be active and will excise the
floxed Hells-tm1c allele, making them null for Hells in spermatocytes. I used these Hells-tm1d/Hellstm1c; Stra8-iCre males to study the effects of loss of Hells in meiosis.
In some progeny from the Hells-tm1c; Stra8-iCre sires there was evidence of incomplete
conversion of the Hells-tm1c allele to Hells-tm1d (Fig. 5D, star). To mitigate this effect, I used the Hellstm1d/+; Stra8-iCre males from my final cross as sires in future matings, so the germ cells of these sires
would have another round of exposure of Cre, which should eliminate any residual intact Hells-tm1c.
The additional round of Cre exposure worked, where I sometimes saw residual Hells-tm1c in offspring
from a Hells-tm1c/+; Stra8-iCre/+ sire, but not in offspring from a Hells-tm1d/+; Stra8-iCre sire.
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CHAPTER 7
HELLS CONDITIONAL KNOCK DOWN PHENOTYPE
7.1. Hells conditional knock down males are infertile and have reduced testis size
The Hells-tm1d/Hells-tm1c; Stra8-iCre mice were phenotypically normal, grew well, and looked similar
to their littermates. I performed fertility testing on four Hells-tm1d/Hells-tm1c; Stra8-iCre adult males by
mating them to proven fertile female B6 mice for 12 weeks, and none of the sires produced pregnant
dams or any litters. I sacrificed the sires and compared their testis morphology to wildtype controls. All
of the Hells CKO testis were much smaller in size than the wildtype, similar to the PRDM9 CKO
phenotype (Fig. 6A). To quantify this comparison, I plotted the ratio of the total body weight of the
males to the total weight of its two testes and could see that the testis:body weight ratio for the Hells
CKO was significantly lower than the wildtype (Fig. 6B).
7.2. Western blot analysis of testis protein from Hells CKO shows absence of HELLS
To confirm that the knock down of Hells in spermatocytes was successful, I performed western blot on
12dpp testis protein from Hells CKO, heterozygous, and wildtype littermates. I blotted for HELLS and saw
absence of HELLS in the CKO and reduced level of HELLS in the heterozygote, compared to normal levels
in the wildtype (Fig. 6C). This confirmed that our mating strategy and the Cre excision were effective at
generating a tissue-specific Hells null.
I also blotted for PRDM9 on the same protein samples to check that PRMD9 expression
remained unaffected by knock out of HELLS. Surprisingly, PRDM9 levels were slightly reduced in the
Hells CKO compared to wildtype (Fig. 6C). I collected three additional replicates of Hells CKO and control
littermates and performed HELLS and PRDM9 blots in triplicate with b-TUBULIN as a loading control and
confirmed that indeed there was an ~20% reduction in PRDM9 protein in Hells CKO compared to
matched controls (Fig. 6D). However, we ruled out that this slight reduction in PRDM9 protein could
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cause the infertility phenotype in the Hells CKO since heterozygous PRDM9 mice have ~50% reduction in
PRDM9 protein but still activate hotspots, albeit at a slightly reduced efficiency, and complete successful
meiosis (Baker et al., 2015). We can only speculate that the loss of binding between HELLS and PRDM9
in the Hells CKO somehow affects PRDM9 protein half-life or that presence of HELLS somehow regulates
PRDM9 transcription.

Figure 6. Hells CKO testis show infertility phenotype. (A) and (B) Comparison of testis size between
Hells CKO and wildtype. (C) Western of testis protein showing levels of HELLS and PRDM9. (D)
Normalized PRDM9 expression from 4 replicate Hells CKO testis as a fraction of wildtype. PAS
staining of testis sections from (E) 6-week adult and (F) 12 dpp juvenile from wildtype and Hells CKO.
(G) IHC staining for yH2AX, HELLS, and PRDM9 in adult Hells CKO testis.

7.3. Histological analysis of Hells CKO seminiferous tubules show arrest at stage 10 of
spermatogenesis
I investigated the effects of Hells CKO in testis by examining their morphology in histological sections. I
harvested testis from Hells CKO and Hells het littermates, as well as C57BL/6J wildtype control. I
collected testis from both juvenile 12dpp males and adult 6-week old males and fixed the testis
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overnight at room temperature in Bouin’s solution, which is a good fixative for fixing soft tissue and
gives crisper and better staining for nuclei. The next day, I washed the fixed testis in three 1 hour washes
of 70%, 50%, and 25% EtOH and then stored them in H2O to remove excess pigment from the fixed
tissue. I brought the fixed tissue to the Histology core to be embedded in paraffin, cross-sectioned, and
stained with PAS to look at cellular morphology and organization. I took the 5 µm PAS-stained slides and
submitted them to our Microscopy for Nanozoomer imaging at 40X.
I evaluated the images and it was immediately evident that the Hells CKO tubules were devoid
of mature sperm and had empty tubules lacking cells (Fig. 6E). Because in adult testes spermatogenesis
is asynchronous, each cross-section of tubules will capture individual tubules at different stages in
spermatogenesis. Thus an experienced eye can identify the whole spectrum of stages in a sufficiently
representative testis cross-section. Because I do not have the requisite experience, I consulted another
scientist, Hui Tian, for her expert opinion. She analyzed the histological images and concluded that the
Hells CKO were arresting at stage 10 of spermatogenesis, where she could find evidence of cells types
leading up to that stage but none of the more mature cell types from subsequent stages. Stage 10 in
spermatogenesis includes spermatocytes progressing through the pachytene stage of meiosis. Arrest at
stage 10 means arrest at pachytene stage in meiosis, the same as seen in PRDM9 knock out and many
other fertility phenotypes involving meiotic arrest.
In contrast, PAS-staining on 12 dpp testis for both Hells CKO and wildtype showed no difference
in morphology. The tubules in both Hells CKO and wildtype 12 dpp mice have not yet progressed into
stage 10 and there appear to be no effects from loss of Hells (Fig. 6F). Both testes show equal
proportions of tubules in each stage, so the meiotic arrest we see later is not due to pre-meiotic
retardation in spermatogenesis in the Hell CKO but is only initiated when Hells CKO cells progress into
pachytene stage.
7.4. IHC on Hells CKO testis shows loss of HELLS in spermatocytes
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I performed IHC for HELLS, PRDM9, and yH2AX on adult Hells CKO and wildtype testis sections and saw
loss of HELLS in meiotic cells in the Hells CKO. The L/Z tubules still stained well and normally for PRDM9,
but there was no concurrent HELLS signal in the Hells CKO (Fig. 6G). I could see evidence of specificity of
the Stra8-iCre by the presence of HELLS in pre-meiotic spermatogonia, before Stra8 is expressed, in cells
lacking PRDM9 signal. This is good for the integrity of our experiment, because it means the phenotype
we see in the Hells CKO is specific to meiosis and is not due to some unknown function of Hells in
spermatogonia. The staining for PRDM9 looked normal and equal intensity in the Hells CKO testis
compared to the wildtype, indicating that meiotic arrest is not due to loss or misexpression of PRDM9.
As a side note, I did see a small number of Hells CKO tubules that were able to progress through
meiosis and produce sperm. When I performed IHC for HELLS in the Hells CKO sections I saw that some
tubules still expressed HELLS despite carrying Stra8-iCre, and these were the tubules with sperm. This is
due to incomplete excision of the conditional allele by Cre, which has also been described by other
investigators using the Stra8-iCre allele (Tian et al., 2018).
7.5. TUNEL staining shows increased apoptosis in Hells CKO tubules
We predicted that absence of mature sperm and empty tubules meant that cells were undergoing
apoptosis after arrest at stage 10. To confirm this, I stained Bouin’s fixed sections from Hells CKO and
Hells heterozygous testis with the In Situ Cell Death Detection Kit (Roche). The kit labels dying cells by
detecting DNA degradation that is a hallmark of apoptosis. The DNA double-stranded breaks can be
detected by polymerization of fluorescently labelled nucleotides that cleave to the free 3’ OH of the
breaks. This method has also been termed TUNEL (TdT-mediated dUTP-X nick end labeling). To use the
kit, I first needed to prepare my sections by dehydrating them to remove all fixation solution and tissue
fluid and then rehydrate them in PBS. I performed two washes in xylene followed by 100%, 95%, 80%,
and 70% ethanol and then two washes each in H2O and PBS. Next, I incubated the tissue with 20 µg/µl
proteinase K for 5 min at RT to permeabilize the cells. I rinsed twice with PBS to remove proteinase K
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and labelled according to manufacturer’s recommendation. Once the sections were labeled, I co-stained
with DAPI to identify nuclei and imaged the slides for fluorescence from the TUNEL staining (488nm,
green) and fluorescence from the DAPI (405nm, blue). The difference in number of cells stained for
apoptosis for the Hells CKO was immediately evident. Hells CKO tubules in stage 10 of spermatogenesis
had lots of dying cells, compares to almost none in the wildtype control (Fig. 7A). I counted numbers of
TUNEL-positive cells in six tubules from Hells CKO compared to six tubules from Hells wildtype and saw a
large increase in apoptosis due to the loss of later stage germ cells (Fig. 7B).
7.6. Meiotic chromosome spreads show lack of pachytene and diplotene cells in Hells CKO
My results from IHC on testis sections showed arrest at stage 10 of spermatogenesis, but to look closer
at individual cells undergoing meiosis I made chromosome spreads of spermatocytes to identify the
cause of arrest.
7.6.1. Preparing chromosome spreads
I harvested testis from 12 dpp Hells CKO and wildtype littermates and placed them in hypotonic
extraction buffer (30 mM Tris pH8.2, 50 mM sucrose, 17 mM sodium citrate, 5 mM EDTA, 2.5 mM DTT, 1
mM PMSF). I used Dumont forceps to gently pull apart the tubules into a fluffy cloud to allow access of
the lysis buffer. After 30 min lysis, I took small amount (half a grain of rice-sized) of testis tissue and
placed it in 0.1 M sucrose. I used forceps to cut tissue in ‘steak-like’ manner, lifting and dropping
tubules to release cells into the sucrose until the mixture became cloudy. Next, I coated a clean slide in
100 µl fresh 1% PFA, then dropped 7µl of testis/sucrose solution in one upper corner and tilted slowly
back and forth like a making a “Z” all the way down the length of the slide. I put the slides with
chromosome spreads in a humid chamber overnight at room temperature, then the next day took them
out and let them air dry until all liquid evaporates, about 30min. After drying, I rinsed the slides in 0.04%
Kodak Photo-Flo for 60min before storing them at -20°C.
7.6.2 Immunofluorescence on chromosome spreads
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For immunofluorescence, I first blocked slides and permeabilized them by covering them completely in 3
mg/mL BSA, 1% normal donkey serum, and .005% Triton-X 100 in 0.05 M TBS, laying a strip of Parafilm
on top of the slide to further reduce evaporation, and incubating at room temperature for ~6 hrs in a
humid chamber. After blocking, I co-stained the chromosome spreads with anti-HELLS and anti-SYCP3
(1:500 Santa Cruz SC74569, lot#J1314) or anti-HELLS and anti-yH2AX, using the same dilutions as I did
for testis sections and incubated them overnight at 4°, covered with coverslips and sealed with rubber
cement to prevent evaporation. The next day I performed washes and added fluorophore-labeled
secondaries, and finally added antifade with DAPI before sealing the slides with coverslips and sewing
them shut with clear nail polish.
I chose SYCP3 as a marker protein to show the progress of synapsis of chromosomes. SYCP3 is a
synaptonemal complex protein that coats paired homologous chromosomes. The signal is diffuse in
leptotene phase, but then starts to condense along paired chromosome in zygotene phase, where the
signal looks thin and “tangled” as the chromosomes start to pair along their length. In pachytene phase
the chromosomes become completely paired and compacted, and the signal looks fat and stubby. I also
used yH2AX as a marker protein to show unresolved double-stranded breaks, which we would expect to
see if PRDM9 does not activate hotspots and SPO11 instead cuts at promoters or other H3K4me3marked regions of the genome, locations that will not be resolved in the course of meiosis (Brick et al.,
2012).
7.6.3. Chromosome spreads from Hells CKO are devoid of pachytene cells and carry unrepaired DSBs
The composition of chromosome spreads from Hell CKO testis was very different from wildtype spreads.
In the wildtype, most cells were either pachytene or diplotene phase. In contrast, most of the cells in the
Hells CKO were in zygotene phase and had very few cells in pachytene phase. I counted 200 cells from
each Hells CKO and Hells wildtype spreads and scored them for meiotic stage to quantify the arrest of
meiotic progression (Fig. 7C). The Hells CKO showed 56% of cells in zygotene and only 20% in pachytene,
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as opposed to 6% of cells in zygotene for the wildtype and 58% in pachytene. Most of the Hells CKO
pachytene phase cells showed evidence of unresolved DSBs, which appeared as yH2AX staining on parts
of autosomes outside of the sex body, or SYCP3 staining that looked uncompacted in parts of the
chromosomes (Fig. 7D). The Hells CKO appears enriched for zygotene-stage cells because the
spermatocytes cannot progress into or past pachytene stage.

Figure 7. Hells CKO testis show arrest at pachytene stage and apoptosis compared to wildtype. (A)
TUNEL staining on Hells CKO and wildtype adult testis sections. (B) Number of TUNEL-positive cells
per tubule. (C) Percentages of cells in each stage of meiosis counted from chromosome spreads. (D)
Example of incomplete synapsis and persistence of yH2AX staining in Hells CKO “pachytene-like”
cells compared to wildtype pachytene cells. (E) Staining for DMC1 foci in zygotene stage cells and (F)
number of DMC1 foci per cell for Hells CKO and wildtype.

7.7. Staining of chromosome spreads for DMC1 shows unresolved meiotic DSBs
DMC1 is a meiosis-specific protein that binds to single-stranded DNA caused by DSBs at PRDM9-bound
hotspots. Because we saw persistent yH2AX staining we wondered whether these were meioticallyprogrammed DSBs and would label with DMC1. I stained a slide of chromosome spreads from 12 dpp
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Hells CKO and wildtype with DMC1 and SYCP3. In the wildtype spreads I saw punctate DMC1 staining at
DSB foci along the length of zygotene-stage chromosomes and no DMC1 staining in fully synapsed
pachytene-stage chromosomes. Interestingly, the Hells CKO also showed DMC1 foci along zygotenestage chromosomes but the foci persist in pachytene-like chromosomes (Fig. 7E). This evidence shows
that meiotic double-stranded breaks are persisting after zygotene and are preventing the chromosomes
from fully synapsing. The phenotype is similar to the Prdm9 knock out, where misdirected meiotic DSBs
are unable to participate in homologous recombination and remain unrepaired, causing a block in
pachytene. I checked to be sure that the persistent DSBs in the Hells CKO were not due to an increase in
the number of DSBs compared to wildtype by counting the numbers of DMC1 foci per cell during
zygotene. The numbers of DSBs in Hells CKO and wildtype zygotene-stage cells are not significantly
different (Fig. 7F). Therefore, the meiotic block is due to unrepaired DSBs that impede chromosomal
synapsis.
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CHAPTER 8
HOTSPOTS FAIL TO ACQUIRE ACTIVE HISTONE MARKS AND OPEN CHROMATIN IN HELLS CKO
Given our phenotype of meiotic arrest at pachytene phase and evidence of unresolved meiotic DSBS, we
next investigated how the loss of HELLS affects chromatin configuration at hotspots.
8.1. Loss of HELLS leads to loss of ATAC peaks at hotspots
I performed ATAC-Seq on 12dpp Hells CKO and Hells wildtype, two replicates of each genotype. I
processed the sequencing data with our pipeline for mapping, calling peaks, and normalizing read
counts. For both genotypes, the ATAC-Seq passed QC and showed good enrichment at TSS’s. However,
there was a serious batch effect in the ATAC-Seq data between the first set of ATAC performed on Hells
CKO and het ATAC littermates and the second set, where batch explains 67.9% of the variance (Fig. 7A). I
used edgeR ‘removeBatchEffect’ to correct for known batch effect in the samples. After batch
correction, genotype now explains 62.7% of the variance (Fig. 8B) and the replicates are highly
correlated (Pearson’s r=0.98 for CKO and Pearson’s r=0.98 for het).
After annotating the peaks as hotspots, promoters, or other, I plotted the change in open
chromatin at peaks between Hells het and Hells CKO. There was a clear population of sites that were
drastically reduced in the Hells CKO that appear to be exclusively hotspots (Fig. 8C). Of the 1,391
hotspots found in the ATAC peakset, 91% of them are reduced in the Hells CKO. In contrast, promoters
show very little variation between Hells CKO and het (Fig. 8D). I looked at ATAC-Seq read pile-ups on the
UCSC browser and confirmed the Hells CKO lost enrichment of reads at known hotspot locations
compared to the het (Fig. 8E). Using CoverageView to count ATAC reads across the 7,233 hotspots
shows loss of ATAC enrichment in the Hells CKO, except for some low strength hotspots that appear to
have generalized open chromatin around them in both the CKO and the het (Fig. 8F). These results
indicate that open chromatin at hotspots is obviated with loss of Hells.
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These ATAC-Seq results from Hells CKO are in keeping with our hypothesis that Hells is the
causative protein that opens chromatin at hotspots in meiosis. To validate this conclusion, we still
needed to prove that PRDM9 was present at hotspots in the Hells CKO. Otherwise, the loss in chromatin
remodeling could be due to loss pf PRDM9 binding, and not lack of Hells.

Figure 8. ATAC-Seq on Hells CKO shows loss of open chromatin at hotspots. (A) MA plot of
differentially accessible ATAC peaks between Hells CKO and wildtype. Hotspots are colored in blue.
(B) MA plot of differentially accessible peaks at promoters. (C) Heatmap of ATAC read counts across
a 2 kb region centered over 7,233 individual hotspots. (D) Bedgraph of read pile-ups at a single
hotspot. (E) Density plot of wildtype ATAC reads across a 2 kb region centered on all hotspots. (F)
Density plot of Hells CKO ATAC reads across a 2 kb region centered on all hotspots.

8.2. ChIP for H3K4me3 shows failure of hotspots to acquire activated marks in Hells CKO
Chromatin immunoprecipitation (ChIP) is a technique to look at interactions between protein and
chromatin. Like co-IP, the method uses magnetic beads conjugated with an assay-specific antibody to
pull down a target protein along with the chromatin to which it was bound. Using ChIP, we can
investigate what DNA sequences are bound by the protein of interest or locations of histone
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modifications. For our first ChIP on Hells CKO, I used an antibody directed to H3K4me3. Activated
hotspots are known to acquire H3K4me3 only after binding by PRDM9 (Baker et al., 2014; Buard et al.,
2009; Eram et al., 2014; Sun et al., 2015; Wu et al., 2013). In fact, our lab typically uses H3K4me3 ChIP as
a proxy for PRDM9 binding because the H3K4me3 histone mark is so strong in response to PRDM9
binding.
8.2.1. Preparation of cross-linked chromatin for H3K4me3 ChIP
For each ChIP, I harvested testes from 4-5 12 dpp male pups and pooled them to make one replicate. I
collected 3 replicates of each Hells CKO and Hells het littermates and extracted spermatocytes as
described for H3K4me3 ChIP (Baker et al., 2014). After washing with PBS, I cross-linked the cells with 1%
formaldehyde for 10 min to preserve the protein-DNA complexes before stopping the reaction by
adding 125 mM glycine to quench unreacted formaldehyde. Cross-linking cells forms covalent bonds
between protein and DNA or protein and other proteins, stabilizing interactions subsequent
experiments.
8.2.2. Lysis of spermatocytes and digestion of cross-linked chromatin with MNase to fragment DNA
After cross-linking, the cells are hypotonically lysed in 10mM Tris-HCL pH 8.0, 1mM KCl, 1.5 mM MgCl2
with 1 mM PMSF and 1 X protease inhibitor cocktail for 30 min to release nuclei containing the proteinbound DNA. Hypotonic lysis conditions challenge the cell membrane with low-salt conditions, causing
the cell to swell and rupture to release nuclei, then high-speed pelleting recovers the nuclei from
solution. The intact chromatin from the recovered nuclei is much too large to be efficiently pulled down
by ChIP, and even if it was, the resulting DNA would be too long to determine precisely where the
protein of interest in bound. For these two reasons, chromatin is fragmented before being used in ChIP.
For ChIP for histone modifications, like H3K4me3, we take advantage of the fact that DNA wrapped
around nucleosomes is relatively compacted, making the histone-bound DNA of interest protected from
micrococcal nuclease (MNase), an enzyme that cleaves protein-unbound regions of DNA. Digesting the
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chromatin with MNase results in soluble mononucleosome-length fragments ~150bp, plus any surviving
di- and tri-nucleosome fragments. Two high-speed spins help purify the digested chromatin that remains
in solution away from other cellular debris.
8.2.3. Performing IP for H3K4me3 and collection of DNA fragments
The protocol for H3K4me3 ChIP is described in Baker et al., 2014. The IP is performed in RIPA buffer
augmented with 50 mg/mL BSA to reduce non-specific protein interactions with the beads and
0.5mg/mL Herring sperm DNA to reduce non-specific DNA interactions with the beads. First, I
conjugated 7.5 µl of anti-H3K4me3 antibody (Millipore, 07-473) to 60 µl Protein G Dynabeads for
>20min in 300 µl buffer, and afterward washed to remove unbound antibody. I added 3 mln cells’ worth
of chromatin to the antibody-bound beads in 300 µl total buffer and incubated at 4° for 2 hrs. After
washing to remove unbound chromatin, I harvested the DNA fragments using an elution buffer
containing high SDS to elute the complexes from the beads, high NaCl to reverse cross-links, and
proteinase K to digest the protein away. The remaining DNA I purified using a Zymo DNA Clean and
Concentrator kit.
8.2.4. Analytical ChIP-qPCR shows reduced H3K4me3 at Pbx1 hotspot in Hells CKO
To test whether our H3K4me3 ChIP was successful, I tested our purified H3K4me3 ChIP DNA by qPCR to
look for enrichment of sequences pulled down from hotspots. I would have tested my ATAC libraries by
qPCR and I tried to develop an assay, but the variable fragment length as locations probably contributed
to me being unable to amplify a product from ATAC. However, qPCR is an excellent measure of histone
ChIP enrichment for specific sequences. For PRDM9Dom2 on a B6 genetic background, I chose two
hotspots that are particularly active and show strong H3K4me3 binding at the flanking nucleosomes next
to the PRDM9 binding site and used primer sets that amplify the nucleosome-occupied region next to
the strong B6 hotspot. I also used primers sets that amplify next to a strong hotspot for PRDM9Cst as a
negative control and the Actin promoter region as a positive control. Contrary to our expectations, I saw
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strongly reduced levels of enrichment at Pbx1 in the Hells CKO, compared to strong enrichment in the
Hells heterozygous control (Fig. 6A). Both samples showed low enrichment for the PRDM9Cst hotspot
negative control and the high enrichment for the housekeeping gene promoter.
8.2.5. H3K4me3 ChIP-Seq shows reduced H3K4me3 at all hotspots in Hells CKO
We sequenced the three replicates of H3K4me3 ChIP for both Hells het and Hells CKO, ~50mln reads per
sample, single-end. I mapped the reads with bwa, called peaks with MACS, and normalized reads in a
shared peakome. I looked at QC metrics for the H3K4me3 ChIPs to confirm the assay was efficient and
specific. The fraction of H3K4me3 reads that were found in peaks (FRiP) was high in all samples (30-50%)
and replicates showed very good agreement with each other (Pearson’s r > 0.95). Most of the 71,877
peaks annotated as hotspots that showed significant reduction in the Hells CKO (Fig. 9B). Of the 6,821

Figure 9. H3K4me3 ChIP-Seq on Hells CKO shows loss of signal at hotspots. (A) H3K4me3 ChIP qPCR
showing loss of enrichment at hotspots in the Hells CKO. (B) MA plot of differential H3K4me3 peaks
between Hells CKO and wildtype, with PRDM9 ChIP-defined hotspots colored in blue (C) Heatmap of
H3K4me3 read counts across a 2 kb region centered over 7,233 PRDM9 ChIP-defined hotspots. (D)
Read depths across a 3kb region at a single hotspot. (E) Density plot of wildtype H3K4me3 reads
across all hotspots. (F) Density plot of Hells CKO H3K4me3 reads across all hotspots.
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H3K4me3 peaks showed similar trimethylation patterns in both the Hells CKO and Hells het. However,
H3K4me3 peaks annotated as hotspots, 98% of them are reduced in Hells CKO compared to wildtype. A
heatmap of read depths across all hotspots shows comprehensive depletion in the Hells CKO (Fig. 9C).
I visualized the read coverage profile for Hells CKO and wildtype H3K4me3 ChIP using the UCSC
browser and found significant decrease, loss, or disorganization (nucleosomes not remodeled around
PRDM9 motif) of the H3K4me3 signal at hotspots in the Hells CKO (Fig. 9D). Likewise, aggregate signal
from all hotspot regions show almost complete loss of H3K4me3 organization at hotspots in the Hells
CKO (Fig. 9F) compared to the control.
There were 11,070 peaks that were greater than 2 logFC reduced in the Hells CKO, which I
hypothesized were hotspots. However, for most of my analyses I used a smaller hotspot peak set of
7,233 hotspots identified by PRDM9 ChIP binding that have PRDM9 motifs identified within them, a
conservative measure of a true hotspot. I found 6,821 of these hotspots in my H3K4me3 ChIP data, of
which 6,677 (98%) are reduced in the Hells CKO, but that leaves many H3K4me3 peaks that are
significantly reduced in the Hells CKO unannotated. I wanted to annotate more of the 11,070 H3K4me3
peaks that are reduced in Hells CKO as hotspots by using a larger list of hotspots from Spruce et al, 2020.
Here we defined hotspots based on their unique chromatin signature using ChromHMM analysis (Ernst
and Kellis, 2017) to assign chromatin-state signatures at genomic regions by using a multivariate hidden
Markov model (HMM) that explicitly models the combinatorial presence or absence of each mark. Using
the larger pool of 17,843 hotspots identified by ChromHMM I annotated 11,125 H3K4me3 peaks as
hotspots, of which 11,121 were reduced in the Hells CKO. These results strongly support my hypothesis
that the peaks reduced in Hells CKO are hotspots. There were still ~919 peaks that are reduced greater
than 2 logFC in the Hells CKO but are not annotated. These unannotated peaks represent 1.2% of the
total 71,877 peaks called in the H3K4me3 ChIP data, compared to 9.5% - 15.5% that are annotated as
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hotspots. It is unclear if the remaining peaks are unannotated hotspots or something else, but the
overwhelming majority of the peaks that decrease or disappear in the Hells CKO are hotspots.
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CHAPTER 9
HELLS LOCALIZES TO HOTSPOTS DURING MEIOSIS
9.1. ChIP for HELLS shows binding at hotspots
The molecular and morphological phenotype of the Hells CKO strongly indicate that HELLS in necessary
for initiation of meiotic recombination. To provide a functional link between HELLS and hotspots I
wanted to test whether HELLS bound on chromatin at hotspots by performing HELLS ChIP. Before I could
do this, we needed to develop a protocol for ChIP on a protein that may not directly bind DNA (HELLS)
and interacts through another protein partner with DNA-binding capabilities (PRDM9).
9.1.1. Dual cross-linking spermatocytes to preserve HELLS interactions with chromatin
For the HELLS ChIP, I modified our cross-linking to include a two-step cross-linking process to target both
protein-DNA interaction and protein-protein interactions. Since HELLS has no DNA binding domain of its
own, we speculated that it could only be recruited to chromatin through another DNA-binding protein,
like PRDM9. Therefore, in order to recover chromatin from the HELLS ChIP, we would need to perform
dual cross-linking to first cross-link protein-protein interactions (e.g. HELLS to PRDM9), then crosslink
protein to DNA (e.g. PRDM9 to chromatin). Protein-protein interactions were cross-linked starting from
12 dpp spermatocytes using fresh disuccinimidyl glutarate (DSG) at 2 mM in PBS with 1 mM MgCl2 for 30
min at room temperature with rotation. Next, I added 1% fresh paraformaldehyde to cross-link proteinDNA interactions and rotated another 5 min before stopping the reaction by adding 125 mM glycine to
quench unreacted formaldehyde.
9.1.2. Sonication of chromatin to fragment the DNA before ChIP
In order to make DNA compatible with high-throughput sequencing and improve enrichment over
background, longer pieces of chromatin need to be fragmented. Since HELLS is expected to create
nucleosome-free DNA, I could not use MNase-digestion without potentially digesting away the DNA of
interest. Instead, I used sonication to break the DNA through ultrasound waves that can cleave
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hydrogen bonds and shear DNA while leaving proteins unharmed. There are four considerations for
successful sonication: time, SDS concentration, heat, and intensity. Sonication sheared DNA by vibration,
which also produces heat that can damage proteins. To control the heat, the Covaris sonication
equipment maintains the sample in a temperature-controlled water bath. The Covaris has adjustable
setting for intensity of sonication and length of time of sonication bursts. We followed the
manufacturer’s recommendation for intensity: Duty 2%, Peak Incident Power 105 watts, Cycles per burst
200.
For length of time I tested three conditions, 5min, 10min, and 15min. I also tested two
concentrations of SDS. SDS increases sonication efficiency and chromatin yield, but downstream is
strongly interferes with ChIP binding efficiency. Therefore, I tested the recommended concentration for
sonication, which was 1% SDS, and the recommended maximum concentration for ChIP, which was
0.1%. For my sonication test I hypotonically lysed dual cross-linked cells and aliquoted them into six 1
million cell aliquots in 130 µl for sonication, the maximum cell concentration recommended for
sonication. I tested three different time conditions using two different SDS conditions. I took the
resulting sonicated DNA, reversed cross-links and digested protein, and then ran the DNA fragments on
a gel to analyze fragment size (Fig. 11A). The low SDS condition lost most chromatin, and what was left
appeared unsonicated. The high SDS concentration showed good sonication in all three times. My aim
was to recover DNA fragments around 300-600bp, which appeared to be in between 10 and 15 min.
Based on these results I decided to sonicate my samples for 12min.
9.1.3. Dialysis of chromatin to reduce SDS
The optimum concentration of SDS in a ChIP assay is 0.1%, and my sonicated chromatin was at 1%. If I
diluted my chromatin to 0.1% in ChIP buffer, the chromatin would be too dilute to bind efficiently in the
ChIP. To reduce SDS concentration without increasing volume, I dialyzed the sonicated chromatin
overnight in low-SDS dialysis buffer (0.01% SDS, 1.1% triton X100, 1.2 mM EDTA, 16.7 mM Tris-Cl pH 8.0,
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167 mM NaCl) using Slide-A-Lyzer Mini Dialysis Devices, 10K MWCO, that will allow small molecules like
SDS to pass through and equilibrate but keep the chromatin inside. Previous work in our lab (Baker et
al., 2015a) determined that optimal dialysis requires an initial 1:1 dilution of sonicated chromatin to
dialysis buffer and then two >8hr incubations in successive 1L dialysis buffer baths at 4°.
9.1.4. Performing IP for HELLS and recover co-bound DNA
The HELLS ChIP required more gentle buffer conditions than the H3K4me3 ChIP. Instead of using RIPA
buffer, which is relatively harsh buffer with high detergents (50 mM Tris pH 8.0, 150 mM NaCl, 1.0% NP40, 0.5% Na deoxycholate, 0.1% SDS), I switched to using dialysis buffer (16.7 mM Tris-Cl pH 8.0, 167
mM NaCl, 1.1% triton X100, 1.2 mM EDTA, 0.01% SDS) that is less likely to disrupt weak antibody binding
but is also more prone to non-specific background signal. As blocking agents, I used 50mg/mL BSA and
2mg/mL polyglutamate. Polyglutamate is water-soluble synthetic polymer that mimics DNA in its ability
to neutrally coat but not bind the components in the ChIP assay. We made this change after finding
evidence of non-mouse DNA sequence in our ChIPs using the gentle buffer, which we concluded came
from Herring sperm DNA that was able to bind to beads in the less stringent buffer conditions.
For the HELLS ChIP, I performed three triplicate 500 µl ChIP reactions containing 25 µl Protein G
beads, 4 µl anti-HELLS antibody (Millipore, ADB41), and chromatin from 3 million dual cross-linked cells.
I also performed a negative control ChIP using anti-IgG antibody that does not bind protein and
represents non-specific binding. The next day I performed gentle washing with low salt, high salt, and
LiCl washes described in the PRDM9 ChIP protocol in Baker et al., 2015a. To purify the DNA from the
HELLS ChIP, I used a three-step process to elute from the beads, reverse cross-links, and digest protein,
also described in the PRDM9 ChIP protocol in Baker et al., 2015a. The yield from the HELLS ChIP after
purifying the ChIP DNA with the Zymo DNA Clean & Concentrator-5 (Zymo # D4013) kit was significantly
lower than the yield from H3K4me3 ChIP, about 3.2 ng total ChIP DNA for HELLS compared to 10 ng ChIP
DNA for H3K4me3.
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9.1.5. qPCR on HELLS ChIP DNA shows enrichment at hotspots
I chose to use B6CAST-KI mice for the HELLS ChIP because my previous HELLS ChIPs on B6 mice were very
low yield, and though the qPCR showed the results we expected (HELLS enrichment at hotspots), it was
low efficiency. We have seen poor outcomes from B6 in the PRDM9 ChIP previously, and the resolution
was to use B6CAST-KI with the stronger allele of PRDM9 to capture more fragments. I compared HELLS ChIP
on replicates of B6 vs B6CAST-KI spermatocytes and saw that I could double my yield (3.2ng vs 1.7ng) and
relative enrichments at hotspots (3.1-fold vs 1.6-fold over control) by using B6CAST-KI vs B6. I performed
HELLS ChIP on three replicates of B6CAST-KI spermatocytes followed by qPCR to measure enrichment at
hotspots and found HELLS was preferentially bound at PRDM9Cst hotspots compared to PRDM9Dom2
hotspots (Fig. 11B). Compared to the replicates of HELLS ChIP on B6 spermatocytes, the enrichment at
hotspots in HELLS ChIPs was specific to binding of PRDM9 and allele-specific hotspots.
9.1.6. Sequence analysis of HELLS ChIP shows enrichment at hotspots
We sequenced our two best HELLS ChIP replicates based on yield and qPCR enrichments and one IgG
ChIP control to a depth of ~50mln reads per sample, single-end reads and I performed mapping, peakcalling, and normalization on the data as before. I checked the correlation between HELLS ChIP
replicates as a quality control and they showed good agreement (Pearson’s r=0.91). Despite >94% reads
mapping, there were only 2,675 HELLS ChIP peaks called at e-5 by MACS, which is low and only about
1,000 more than the number of peaks called on IgG ChIP negative control
I uploaded bedgraph files containing normalized reads from the HELLS ChIP to the UCSC browser
to look at read pile-ups at HELLS ChIP peaks. There was enrichment HELLS reads at hotspots, though not
every hotspot showed enrichment, perhaps as a consequence of poor ChIP efficiency. The hotspots with
HELLS signal showed read pile ups centered over the PRDM9 binding motif, similar to ATAC peaks and in
between H3K4me3 nucleosome peaks (Fig. 11C). It is interesting that although HELLS is a nucleosome
remodeler, we did not see reads at nucleosomes flanking hotspots, like we see in H3K4me3 ChIP.
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Figure 10. HELLS ChIP shows binding at hotspots. (A) Gel of sonication fragments from two SDS
concentrations (1% and 0.1%) and three time lengths (5, 10, and 15min). (B) HELLS ChIP qPCR for
hotspots (C) Bedgraphs of read pile-ups for H3K4me3 ChIP, ATAC, HELLS ChIP, and IgG ChIP at one
hotspot. (D) Pie chart showing annotations of peaks recovered in HELLS ChIP. (E) Heatmap of HELLS
ChIP read counts across a 2 kb region centered over 1,234 individual hotspots.

I annotated the peaks as hotspots, TSS’s, or other and found that 46% of the 2,675 HELLS ChIP peaks
overlapped recombination hotspots, compared to 23% of the peaks at TSS’s (promoters) and 31% that
were “other” (Fig. 11D). This result finding hotspots were the largest proportion of peaks supports the
hypothesis that HELLS plays a role at hotspots. We also saw HELLS peaks at promoters, consistent with
other findings that HELLS can act as an epigenetic regulator at chromatin regulatory regions like
promoters and enhancers (Ren et al., 2019; Han et al., 2017; von Eyss et al., 2011). In contrast, the IgG
negative control ChIP had 1,777 peaks, similar to one of our HELLS ChIP replicates, however only 2% of
those peaks overlapped with HELLS peaks and there was no enrichment for IgG at hotspots, proving that
the HELLS ChIP was truly enriched for at hotspots despite having low sensitivity.
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To examine enrichment across all hotspots, I plotted read counts across a 2kb region centered
over the 1,234 hotspots recovered from the HELLS ChIP and compared it to ATAC, H3K4me3, and IgG
heatmaps. The read depths from HELLS ChIP at hotspots was correlated with read depths from
H3K4me3 ChIP and ATAC, showing that the strongest hotspots had the strongest signal in all three
marks (Fig. 11D). In contrast, the IgG ChIP I performed on the same spermatocytes at the same time
showed no enrichment of any hotspots. These results show that HELLS is bound at hotspots.
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CHAPTER 10
LOSS OF HOTSPOTS IS NOT DUE TO PRDM9 BINDING AT OTHER SITES IN THE HELLS CKO
10.1. No evidence of novel H3K4me3 peaks in Hells CKO
The loss of H3K4me3 was unexpected, since presumably if PRDM9 is still present in the Hell CKO it
should be able to bind and trimethylated hotspots. We questioned whether in the Hells CKO the
hotspots are relocated to other genomic sites by alternative binding by PRDM9 to other sites in the
absence of HELLS. To investigate potential non-canonical binding of PRDM9 in the Hells CKO, I looked
more closely at our H3K4me3 ChIP for emergence of increased trimethylated at sites in the Hells CKO
that could indicate binding by PRDM9. There are very few peaks that are more trimethylated in the Hells
CKO. The changes in H3K4me3 peaks that are differentially trimethylated in the Hells CKO are very
uneven, only 7 peaks increase greater than 2 logFC in the Hells CKO compared to 5,513 hotspot peaks
that decrease greater than -2 logFC reduced in the Hells CKO (Fig. 9B). PRDM9 can deposit H3K4me3 in
vitro on its own without binding partners (Chen et al., 2020), so we would expect to see a new cohort of
H3K4me3 peaks emerge if PRDM9 was binding elsewhere, therefore the H3K4me3 ChIP data shows
strong evidence against relocation of hotspots.
10.2. PRDM9 is not sequestered to TEs in absence of HELLS
There is a potential role of Hells before meiosis occurs in de novo methylation of the germline.
Transposable elements (TEs) become demethylated in fetal germ cells and must be silenced by de novo
methyltransferases or piRNAs. In spermatogenesis, de novo methylation occurs in fetal
prospermatogonia and is completed by E16.5. Interestingly, defects in de novo methylation also cause
defects in meiotic progression and pachytene arrest, a phenotype similar to Hells CKO and Prdm9 KO. De
La Fuente et al., 2006, found evidence of demethylation of transposable elements in Hells KO oocytes in
addition to meiotic arrest at pachytene stage due to unresolved DSBs (De La Fuente et al., 2006). In our
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conditional mouse model, Stra8-iCre is first observed in 3 dpp testes (Sadate-Ngatchou et al., 2008), so
Hells is expressed normally when de novo methylation occurs and the phenotype we see is not due to
demethylation of TEs.
However, it did make us wonder if TEs have the potential to provide binding sites for the zincfinger in PRDM9, given that zinc-finger proteins evolved primarily to recognize and silence TEs. In the
Hells CKO we observe no evidence of PRDM9 binding at hotspots in the Hells CKO but we know PRDM9
protein is present, and we also see no novel genomic locations showing PRDM9 binding based on
increased H3K4me3, therefore we wondered if PRDM9 could be sequestered to unmapped, repetitive
TEs in the absence of HELLS.
To investigate potential PRDM9 binding at TEs, I used SalmonTE to map TE reads from the
H3K4me3 ChIP data. Most mapping algorithms exclude TE sequences because of their repetitive nature
and the accompanying difficulty of assigning reads to an individual TE or location. SalmonTE uses an
expectation-maximization (EM) algorithm and light-weight mapping approach to assign reads to
consensus sequences of TE families (Jeong et al., 2018). I ran SalmonTE to search for reads in the
H3K4me3 ChIPs that show sequence similarity to 275 consensus sequences of known mouse TEs. As
control datasets, I included a Prdm9 KO H3K4me3 ChIP as a negative control, reasoning if we do see
increase in H3K4me3 at TEs in the Hells CKO, that effect should be ablated in the Prdm9 KO. I also also
analyzed previously published H3K4me3 ChIP-seq data from a Dnmt3L (Brick et al., 2018). Since de novo
methylation TEs is dependent on Dnmt3L, we should see an increase in H3K4me3 at TEs in Dnmt3L
knock out if the two are linked.
After normalization and differential analysis, 0 TEs had an increase in Hells CKO greater than 2
logFC of the 275 TE families queried. There were 23 (8%) TEs that showed a logFC > 1, which seems too
low of a difference to be a true change in PRDM9 binding, considering that there are many individual TEs
and therefore many potential binding sites represented by each SalmonTE consensus entry. I normalized
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TE read counts to data from the Hells heterozygous animals and plotted a heatmap to show the change
in H3K4me3 in the Hells CKO, Prdm9 knock out, and Dnmt3L knock out (Fig. 11A). After filtering for TEs
that had a >1 logFC in the Hells CKO, I saw the TEs that appeared to be differentially trimethylated in the
Hells CKO are similarly trimethylated in the Prdm9 knock out, suggesting the increase in H3K4me3 at
these TEs is not specific to PRDM9 binding but may be due to differences in the meiotic stage in the
infertile phenotypes. The Dnmt3L knock out showed stronger differences as expected, but perhaps
unexpectedly for this subset of TEs there was less H3K4me3 at TEs in the Dnmt3L knock out compared
to the Hells het, so clearly our Hells CKO phenotype is not reminiscent of failure of de novo methylation.
In conclusion, the changes in H3K4me3 at TEs in the Hells CKO are not indicative of PRDM9
sequestration to TEs.

Figure 11. PRDM9 is not binding at non-hotspot locations. (A) Heatmap of log2 fold change
compared to Hells het in H3K4me3 read counts mapping to TEs. (B) PRDM9 ChIP qPCR for hotspots
in Hells CKO vs. wildtype.
10.3. PRDM9-ChIP on Hells CKO does not show binding of PRDM9
Although there was no evidence of alternative PRDM9 binding in the H3K4me3 data, I queried PRDM9
directly by performing PRDM9 ChIP on three replicates of Hells CKO 12dpp spermatocytes compared to
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CKO het controls. I followed the ChIP protocol described for HELLS ChIP, but with single cross-linking
instead of dual cross-linking (though I tested PRDM9 ChIP on dual cross-linked cells and saw no
difference in outcome). As mentioned above, the PRDM9 ChIP on B6 with the native Prdm9Dom2 allele is
low efficiency, and the total recovery from all Hells PRDM9 ChIP samples was low. I performed qPCR for
two Prdm9Dom2 hotspots (positives) and one PRDM9Cst hotspot (negative control), along with a genomic
location with no PRDM9 binding that should be equal in all samples to use for normalization. I saw
reduced binding at B6 hotspots in the Hells CKO, supporting previous observations that PRDM9 does not
bind hotspots in the absence of HELLS (Fig. 11B). It is hard to say conclusively that PRDM9 is not binding
at all in the Hells CKO, since enrichment is so low for this ChIP and we see background ChIP signal at
supposedly negative locations. Overall, the PRDM9 ChIP suggests that PRDM9 binding at hotspots is
impaired in Hells CKO, but more optimization would be needed to be absolutely certain.
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CHAPTER 11
CONCLUSIONS
11.1. The chromatin remodeler HELLS creates open chromatin at hotspots
In total my thesis work demonstrated 1. activated hotspots are regions of open chromatin, 2. open
chromatin at hotspots is dependent on PRDM9 and independent of SPO11, 3. HELLS forms a complex
with PRDM9 in testis, 4. Loss of Hells prevents chromatin reorganization at hotspots leading to failure of
homologous recombination. These results advance the field of meiosis by showing a role for open
chromatin at hotspots to allow homologous recombination, and by describing HELLS as a binding
partner of PRDM9 that is necessary for PRDM9 function.
In my first set of experiments, I showed that activated hotspots are locations of open chromatin
by using ATAC-Seq to query nucleosome-depleted regions in the genome. Open chromatin at hotspots is
dependent on PRDM9 binding as shown by allelic differences in open chromatin sites and is
independent of DSBs as shown by presence open chromatin at hotspots in the Spo11 KO where no DSBs
have occurred. In my next set of experiments, I introduced the chromatin remodeler HELLS. I used coIP
to show that HELLS and PRDM9 form a protein complex and performed IHC on testis sections to show
protein co-expression of HELLS and PRDM9 in L/Z stage cells.
To investigate HELLS in male meiosis, I imported a mouse with a conditional knock out allele of
Hells and mated it to Stra8-iCre to knock out Hells expression in spermatocytes starting at L/Z stage in
meiosis. The Hells CKO spermatocytes showed meiotic arrest and apoptosis at pachytene stage due to
unresolved DSBs. The Hells CKO spermatocytes had no open chromatin at hotspots but normal open
chromatin everywhere else, indicating that in the absence of HELLS, nucleosomes are not remodeled at
hotspots. Concurrently in the Hells CKO there was a lack of H3K4me3 histone modifications at hotspots
suggesting loss of PRDM9 binding, however there is no evidence of PRDM9 binding at novel locations in
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the absence of HELLS by H3K4me3 ChIP. Finally, I confirmed that HELLS is preferentially bound at
hotspots by performing a HELLS ChIP in normal spermatocytes, verifying that HELLS is part of the protein
complex recruited by PRDM9 to remodel chromatin at hotspots and allow homologous recombination in
meiosis.
11.2. The role of HELLS in PRDM9 function is unclear
One question that came up repeatedly during this project is what is happening to PRDM9 in the Hells
CKO. I assumed in the Hells CKO that PRDM9 would still bind hotspots and trimethylate H3K4 however it
appears that PRDM9 does not bind at all in the absence of HELLS. In fact, we performed an shRNA knock
down of Hells in cell culture and confirmed loss of PRDM9 binding without HELLS as a co-factor. The lack
of binding is not an issue with protein quantity: we see plenty of PRDM9 protein in the Hells CKO, even if
protein levels are slightly reduced compared to wildtype. However, impaired binding could be explained
if HELLS is a critical binding partner for PRDM9 to be active. There are many protein complexes that
require all protein components to be present before the complex is competent and active. However,
previous papers have shown PRDM9 has methylase activity in purified in vitro assays (Powers et al.,
2016; Chen et al., 2020), so it appears that HELLS protein is not necessary for PRDM9 to methylate
purified histones. HELLS could potentially play a role in allowing PRDM9 to bind DNA, although again
other studies have used PRDM9 in vitro and showed that PRDM9 can bind naked DNA without additional
protein partners (Billings et al.; 2013; Grey et al., 2011).
Another possibility I explored was the potential that PRDM9 was binding elsewhere. I tried
several assays (H3K4me3 and PRDM9 ChIP) and looked at possible binding to TEs, but there was no
evidence to support non-canonical binding. I could not even recover enough DNA from PRDM9 ChIP in
Hells CKO to sequence, suggesting that PRDM9 is not binding anywhere in the genome. We also
performed a DMC1 ChIP on Hells CKO with the help of a collaborator (Hui Tian) from the Paigen Lab to
look for non-canonical DSB sites, but the data returned promoter regions and other H3K4me3-enriched
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loci exactly like Prdm9 KO with no sign of alternative sites. Together these observations suggest that cobinding with HELLS is necessary for PRDM9 to be competent to interact with intact chromatin.
In total, this work describes PRDM9 as a pioneer factor that can recognize binding motifs in
condensed chromatin and deposit open chromatin histone marks to encourage other factors to bind.
Most described pioneer factors behave this way, where the pioneer factor binds first and then open
chromatin and histone marks appear before DNA accessibility (Iwafuchi-Doi and Zaret; 2014; King and
Klose, 2017). In our case the role seems to be reversed: seemingly PRDM9 cannot trimethylate histones
without DNA being accessible. The previous studies showing PRDM9 binding to DNA in vitro used naked
DNA, i.e., DNA that is already accessible and is parsimonious with this explanation. In fact, previous
studies have already shown that chromatin compaction negatively impacts PRDM9 binding efficiency
(Walker et al., 2015). PRDM9 shows transient binding and a short residency time at hotspots (Spruce et
al., 2020), suggesting a weak association that could be easily lost without stabilization by other factors.
Future work will be required to test whether HELLS may act to stabilize PRDM9 binding before activation
of hotspots can occur.
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